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ABSTRACT 
 
The metabolism of Sertoli cells is highly active to maintain nutritional needs 
of germ cells. After glucose incorporation, only 1-3% is converted to glycogen 
suggesting low levels of glycogen synthase. Additionally, expression levels of 
muscular glycogen synthase (MGS), isoform present in these cells, do not 
correlate with the low levels of glycogen. Furthermore, MGS has a predicted 
Rossmann conformation, indicative of enzyme-RNA interaction. The aim of 
this work was to functionally characterize and explore a new feature of MGS 
as RNA binding protein in primary culture of Sertoli cells and the Sertoli 
42GPA9 cell line. MGS was detected in the cytoplasm of Sertoli cells as well 
as in their nucleus. The activity rates of the enzyme were very low indicating 
that MGS is being expressed but is practically inactive. This correlates with 
high levels of MGS phosphorylation suggested by phosphatase treatments of 
Sertoli cells extracts and 2D gel electrophoresis of immunoprecipitated MGS. 
To revert the low levels of glycogen synthesis in Sertoli cells, Protein 
Targeting to Glycogen (PTG) overexpression and lithium treatments were 
performed and confirmed that MGS is present but inactive. Thus, to explore a 
putative new function of MGS in Sertoli cells, the analysis of enzyme 
localization and protein interactions revealed that the enzyme co-localized and 
co-immunoprecipitated with AGO2 and other RNA binding proteins. In 
addition, after the study of MGS interaction with mRNAs by RNA 
inmunoprecipitation coupled to a microarray, several mRNAs were pulled 
down with the enzyme, which was confirmed by mass spectrometry. The 
identities of those mRNAs were classified by molecular function and 
biological processes where the main associated categories were nucleic acid 
binding and transcription, respectively. The results presented in this work 
indicate that MGS is expressed but inactive, and moreover, reveal a novel 
! xii!
function as the interaction with RNAs and RNA binding proteins, suggesting 
that MGS could play an unknown role in the regulation of mRNA expression 
of transcription regulation-related genes in Sertoli cells. 
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1. Introduction 
!
!
1.1 Seminiferous epithelium and spermatogenesis. 
Testes are organs that essentially achieve two functions: sexual hormone 
synthesis and sperm production. Seminiferous tubules are the main functional 
component of the testis, which are organized as a complex stratified 
epithelium. Fundamentally the epithelium is constituted by two cellular 
components: the somatic that corresponds to Sertoli cells, and the germinal 
lineage, where spermatogonia, spermatocytes, spermatids and sperm are 
found [Figure 1A].  
Tight junctions between adjacent Sertoli cells compartmentalize the 
seminiferous epithelium generating the blood-testis barrier [Figure 1, as BTB]. 
This barrier restricts the flow of biomolecules, segregates cellular events 
during spermatogenesis, creates an immunological barrier, and confers cell 
polarity to the seminiferous epithelium (Cheng & Mruk 2012). Polarity is 
manifested by the formation of two compartments where spermatogenesis 
takes place. The basal compartment is in contact with blood vessels, while the 
apical compartment is isolated from the blood flow and faces to the lumen in 
the tubule (Russell 1977). 
Spermatogenesis is a process controlled by several hormones like 
oestrogen, testosterone, follicle-stimulating hormone and luteinizing 
hormone, among others (Alves et al. 2013). Furthermore, the development of 
germ cells is divided into 4 steps: mitosis, meiosis, spermiogenesis, and 
spermiation, which takes nearly 35 days to complete in mice (de Kretser et al. 
1971, Holstein et al. 2003). Spermatogonia are defined as undifferentiated 
germ cells localized to the basal compartment and 3 types are distinguishable: 
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A-singles, known as the germ stem cells; A-paired and A-aligned, which are 
adjacent to the basal lamina of the tubule (Lie et al. 2009). These germ cells 
enter mitosis and some of them will eventually originate type A 
spermatogonia, intermediate and type B spermatogonia (de Rooij & Russell, 
Hess & Renato de Franca 2008) [Figure 1B]. Later, only type B spermatogonia 
will differentiate into pre-leptotenic spermatocytes, which cross the blood-
testis barrier from the basal to the adluminal compartment (Russell 1977) 
[Figure 1B]. Then, pre-leptotenic spermatocytes differentiate into leptotenic 
spermatocytes [diploid germ cells]. Once in this compartment, leptotenic 
spermatocytes develop into pachytene spermatocytes that exhibit 2 meiotic 
processes [primary spermatocytes on meiosis I, and secondary spermatocytes 
on meiosis II], where haploid spermatids are generated (Lie et al. 2009) 
(Figure 1B). Spermatids reach the seminiferous tubule lumen and undergo 
several morphologic changes [spermiogenesis] like chromatin condensation, 
acrosome, tail and residual bodies formation (Lie et al. 2009). At the end of 
spermiogenesis, elongated spermatids are localized in the tubule lumen, 
prepared to be released from the seminiferous epithelium as spermatozoa 
[spermiation] (Lie et al. 2009) [Figure 1B]. In theory, in rodents from each A-
single spermatogonium, 4096 spermatids and thus spermatozoa are generated. 
However, more that 75% of germ cells [spermatogonia, spermatocytes, 
spermatids] undergo apoptosis and degeneration. Thus, the final number of 
spermatozoa from a single spermatogonium is considerably smaller (Cheng & 
Mruk 2012).  
Under physiological conditions the success of spermatogenesis relies on 
several factors, the integrity of Sertoli cell being one of the most important. 
Sertoli cells support germ cell differentiation meiosis and spermatid  
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Figure 1. Seminiferous epithelium and spermatogenesis. A) Seminiferous 
epithelium is composed by Sertoli cells and developing germ cells. Leydig and 
blood vessels are located outside of the tubule in the interstitium. Sertoli cells 
span from the base to the lumen of the tubule with its nucleus normally 
situated at the base. Adjacent Sertoli cells form the blood testis barrier [BTB] 
by tight junctions generating the basal and luminal compartments. Germ cells 
in different stages develop through the epithelium crossing the BTB reaching 
the tubular lumen and detaching as spermatozoa. B) Spermatogenesis scheme 
where type A spermatogonia divides and generates intermediate and type B 
spermatogonia in the basal compartment [left and down]. The latter enters 
mesiosis, where preleptotenic primary spermatocytes cross the BTB, and then 
secondary spermatocytes suffer a second meiosis generating haploid 
spermatids [right]. In the luminal compartment, round spermatids undergo 
spermiogenesis, characterized by the formation of an acrosome, tail and 
residual body to become elongated spermatids, which are released from the 
seminiferous epithelium at spermiation [left and up]. In the middle, a cross 
section of seminiferous epithelium with adjacent Sertoli cells [the nucleus 
located basally, n] and germ cells at different developmental stages depicted as 
brown, purple and blue between the Sertoli cells. Both figures are modified 
from (Lie et al. 2009, Rato et al. 2012b). 
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transformation as well as the nutritional needs of developing germ cells 
(Tarulli et al. 2012; Rato et al. 2012). Structurally, these cells are fixed to the  
basal membrane, and the apex is extended up to the tubular lumen, while the 
cytoplasm exhibits numerous prolongations that envelop germ cells (Weber et 
al. 1983) [Figure 1]. Sertoli cells occupy a volume 17-20% of the seminiferous 
epithelium of adult men. Its number determinates testis size. Yet remarkably, 
each one can support up to 30-50 germ cells at different stages of 
development (Cheng & Mruk 2012, Russell et al. 1990, Sharpe et al. 2003). 
Moreover, these cells regulate the release of mature spermatozoa from the 
seminiferous epithelium, the reabsorption of residual bodies, and the 
phagocytosis of apoptotic germ cells (de Kretser et al. 1971, Nakanishi & 
Shiratsuchi 2004). In this way, spermatogenesis is a highly complex process 
regulated by the hypothalamus-pituitary-testis axis and dependent on 
functional Sertoli cells. 
 
1.2 Glycogen, glycogen synthase, and its regulation 
 
Glycogen is the main form of carbohydrate storage in the human body. It 
is a highly branched D-glucose polysaccharide where glucose can be released 
depending on the needs and stimuli. Glycogen metabolism works under a 
complex regulation involving allosteric factors, covalent modifications, and 
subcellular compartmentalization of key enzymes. Glycogen synthase and 
glycogen phosphorylase represent two central elements in this regulation. 
Different kinases inactivate glycogen synthase by phosphorylation but activate 
glycogen phosphorylase. They trigger the phosphorolysis of glycogen 
molecules and the generation of glucose-1-phosphate. The latter subsequently 
is converted to glucose-6-phosphate. By contrast, dephosphorylation 
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inactivates glycogen phosphorylase and activates glycogen synthase catalysing 
the addition of UDP-glucose to growing glycogen molecules (Shulman et al. 
1995). Two isoforms of glycogen synthase have been described in mammals: a 
liver isoform [LGS] that is tissue-specific, and a muscle isoform [MGS] that is 
not only expressed in muscle, but also in different tissues including adipose 
tissue, kidney, spleen, nervous system and testis (Halse et al. 2003, Nuttall & 
Gannon 1993, Villarroel-Espíndola et al. 2013).  
Hormone signalling generates diverse responses that depend on the target 
tissue, where MGS and LGS are phosphorylated on different serine residues. 
In the case of MGS, Ser7, 10, 640, 644, 648, 652 are phosphorylated by 
GSK3β, AMPK, PKA, PhK CAMKII and casein kinase I and II, which lead 
to the inactivation of the enzyme (Halse et al. 2003, Jensen et al. 2006, Palm et 
al. 2013). From these kinases, GSK3 hierarchically phosphorylates 4 serine 
residues of MGS [Ser640, 644, 648, 652], where the phosphorylation of 
Ser640 and Ser644 potently inactivate the enzyme (Skurat et al. 1994).  
Furthermore, there are other regulators of glycogen synthase. The 
allosteric activator glucose-6-phosphate [G6P] activates the enzyme 
independently of its phosphorylation state (Bouskila et al. 2010). In the 
carboxy terminal region of MGS, an arginine rich segment is crucial for G6P 
allosteric activation. Arg to Ala mutations in this region lose the sensitivity of 
this enzyme to G6P activation (Hanashiro & Roach 2002). Another approach 
to modulate glycogen synthase activity is the change in its subcellular 
localization. Glycogen synthase is diffusedly localized in the cytosol of 
hepatocytes. While in glucose treated cells it accumulates at the cell periphery 
where glycogen deposition appears (Fernández-Novell et al. 1997). 
Likewise, in transfected muscle and hepatic cells with depleted glycogen 
reserves, muscle glycogen synthase accumulates as a nuclear speckled pattern  
! 7!
 
 
 
 
 
 
 
 
 
Figure 2. MGS Phosphorylation sites. Schematic illustration of MGS 
phosphorylation sites. The phosphorylatable serines are indicated below the 
numbered sites that are reported for these residues. The kinases that 
phosphorylate the serine residues are showed over each residue. 
Phosphorylation clusters are presented inside dotted lines. Amino and 
carboxy terminal ends are showed in each extreme. c-AMP dependent protein 
kinase A [PKA], phosphorylase kinase [PhK], calmodulin-dependent protein 
kinase II [CAMKII], AMP-activated protein kinase [AMPK], casein kinase 1 
[CK1], glycogen synthase kinase 3 [GSK3], casein kinase 2 [CK2]. Figure 
modified from (Palm et al. 2013) 
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when cultured without glucose, indicating that nuclear accumulation correlates 
inversely with cellular glycogen content (Cid et al. 2005). On the other hand, 
dephosphorylation is another manner to regulate glycogen synthase activity. 
Protein phosphatase 1 [PP1] is the responsible enzyme for the afore 
mentioned activity. To dephosphorylate glycogen synthase, PP1 must bind to 
glycogen molecules. G-subunits with glycogen specific binding capacity 
accomplish this task directing specifically PP1 to glycogen molecules 
(Hubbard & Cohen 1991). To date, four different G-subunits have been 
identified: GM exclusively expresses in muscle and heart tissue (Hubbard & 
Cohen 1991); GL is only described in the liver (Aggen et al. 2000); Human 
PPP1R5 and its mouse homolog PTG, are found principally in muscle, liver, 
and adipose tissue (Aggen et al. 2000, Brady et al. 1997); while PPP1R6 is 
expressed in all human tissues (Brady et al. 1997). PTG has the capacity to 
direct PP1 to glycogen and also other enzymes involved in glycogen 
metabolism, including glycogen synthase, glycogen phosphorylase, and 
phosphorylase kinase among others (Brady et al. 1997, Printen et al. 1997). 
Thus, PTG acts as a scaffold to assemble the enzymatic machinery of 
glycogen metabolism, and its overexpression is a suitable target to activate 
glycogen synthase. (Printen et al. 1997, Vilchez et al. 2007, Zibrova et al. 
2008).  
Another alternative to activate glycogen synthase by decreasing its 
phosphorylation state is inhibiting the main kinase that inactivates the 
enzyme, Glycogen Synthase Kinase-3 [GSK3]. Lithium is one of the most 
well known inhibitors of GSK3 by competing for magnesium binding site 
(Ryves & Harwood 2001). In adipocyte cells [3T3-L1] and rat skeletal muscle 
cells [L6], lithium effectively inhibits GSK3 activity, stimulates glucose 
incorporation, induces the activation of glycogen synthase, and thus glycogen 
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storage (MacAulay et al. 2003, Oreña et al. 2000). On the other hand, the role 
of GSK3 in the spermatogenic process has been associated with the 
stimulation of DNA synthesis in meiotic preleptotene spermatocytes in mice, 
and as a pro-apoptotic factor in the basal metazoan Hydra (Guo et al. 2003, 
Rentzsch et al. 2005). In male rat testes, subchronic lithium carbonate 
treatments induce the reduction of testes, epididymis, and accessory sex 
organs´ weight, as well as cauda epipidymis and daily sperm count (Thakur et 
al. 2003). Serum testosterone, intratesticular fluid volume, seminal vesicle and 
prostate secretions were also reduced in male rats that were treated with 
lithium (Thakur et al. 2003). Histologically, lithium carbonate treatments 
caused the loss of spermatogenic cells or desquamation of the tubule, and 
specifically the vacuolization and detachment from basal lamina of Sertoli 
cells (Thakur et al. 2003, Zarnescu & Zamfirescu 2006). These effects produce 
a 50% decrease in the fertility index, showing the toxicity of lithium 
treatments to the testicular function (Thakur et al. 2003). Similar results were 
observed in spotted munia [Lonchura punctulata, a seasonal breeding subtropical 
finch], where lithium chloride treatments also produce degenerative changes 
in tubular epithelium (Banerji et al. 2001). In humans, lithium induces a 
significant decrease of sperm motility in vitro (Raoof et al. 1989).  
All these data suggest that testicular injuries observed during lithium 
treatments could be explained by an indirect activation of muscle glycogen 
synthase without discarding the effect over other enzymes affected by lithium. 
 
1.3 Glycogen in Testis  
During mouse sex determination at embryonic stages, Sertoli cell 
differentiation is promoted by Sry [sex-determining region Y] activation that 
upregulates Sox9 in XY gonads resulting in testis formation (Morais da Silva et 
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al. 1996). Testis morphogenesis is initiated by SRY/SOX9 expression and 
requires specific events like cell proliferation of the coelomic epithelium of 
gonads, migration of mesonephric cells, vasculogenesis, cord formation and 
glycogen storage (Matoba et al. 2005, Schmahl & Capel 2003, Tilmann & 
Capel 1999). Glycogen accumulation starts, in pre-Sertoli cells of developing 
mouse XY gonads, shortly after the onset of Sry expression and is reported to 
be necessary for the activation of Sox9, indicating that a readily available 
energy source of glucose is needed for testis morphogenesis (Matoba et al. 
2008). 
In humans, an ultrastructural analysis showed the presence of glycogen 
particles in foetal testis (Fukuda et al. 1975). Whereas from infantile to 
pubertal periods, testicular glycogen content increases (Seilicovich & Pérez 
Lloret 1973). In pathological conditions like cryptorchid testis and unilateral 
varicocele, lower amounts were detected in comparison to normal patients 
(Sultan Sheriff 1984). A detailed study of glycogen content in hamster 
testicular cells during development revealed that in the first day after birth 
seminiferous epithelium cells are almost devoid of glycogen and that only the 
tunica albuginea and arterioles walls were the main source of testicular 
glycogen (Fouquet & Guha 1969). In the first wave of spermatogenesis [≈ 
week 6 in hamsters] there is an increase in glycogen content, mainly present in 
Sertoli cells with respect to germ cells, following a cycle pattern depending in 
the stage of the tubule (Fouquet & Guha 1969). The activity of glycogen 
phosphorylase and glycogen synthase reaches their maximum levels during 
this period. Nevertheless, glycogen phosphorylase activity is always higher 
than glycogen synthase (Fouquet & Guha 1969). Hamsters aged 2 to 4 
months show a small increase of glycogen content, although the activity and 
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presence of glycogen phosphorylase is very insignificant as is glycogen 
synthase activity (Fouquet & Guha 1969). 
Rat testes from different developmental stages show distinctive glycogen 
content. From prenatal to the postnatal first day, glycogen amounts are 20 
times higher in comparison with incoming days including immature, mature, 
and aged stages of rat growth (Gunaga et al. 1972). This effect was described 
precisely in germ cells where glycogen content also declines progressively 
from the immediate postnatal period to adulthood (Leiderman & Mancini 
1969). Nevertheless, as within human pathologic conditions, higher glycogen 
concentration was observed in adult cryptorchid rat testis in comparison with 
control animals (Hárkómen & Kormano 1970). 
Despite lower glycogen levels observed in postnatal testis, its metabolism 
must be intact. Mono-2-ethylhexil-phtalates bind and inhibits glycogen 
debranching enzyme [GDE], interfering with normal degradation rates of 
glycogen and thus its accumulation, causing germ cell apoptosis and testicular 
toxicity (Kuramori et al. 2009). 
In our laboratory we have determined that only the muscular isoform of 
glycogen synthase is expressed in testicular cells, and that enzymatic 
activity/glycogen content is higher during the first postnatal days (Villarroel-
Espíndola et al. 2013). Also, we reported that glycogen synthase 
activity/expression regulation machinery is active in this tissue and that an 
overproduction of glycogen triggers apoptosis in a germ cell line (Villarroel-
Espíndola et al. 2013). These results suggest a negative role of this 
polysaccharide once its metabolism is altered, or specifically, when an 
overproduction develops.  
 
 
! 13!
1.4 Sertoli Cell Metabolism 
Sertoli cells accomplish fundamentally two functions: first, testis 
formation by regulating gonad cell differentiation during embrionary stages, 
and second, act as a mechanical and nutritional support of germ cell 
differentiation being indispensable for spermatogenesis once reached maturity 
(Tarulli et al. 2012). These cells are the main structural component of the 
seminiferous epithelium; their number define testis size occupying between 
17-20% of an adult seminiferous epithelium volume (Russell et al. 1990, 
Sharpe et al. 2003). It has been described that Sertoli cells are capable of 
supporting between 30 and 50 germ cells from different developmental stages 
(Waites & Gladwell 1982). Germ cells have particular nutritional requirements 
that change during development and depend on Sertoli cells (Bajpai et al. 
1998). 
Seminiferous epithelium is highly compartmentalized and oxygen 
deprived, restricting nutrient availability where only Sertoli cells and 
spermatogonia are in direct contact with blood vessels derived fluid (Setchell 
2004, Wenger & Katschinski 2005). Spermatogonia use glucose for ATP 
production, while spermatocytes and spermatids depend on lactate offered by 
Sertoli cells [produced from glucose via glycolysis] (Boussouar & Benahmed 
2004). For these reasons spermatogenesis essentially requires glucose, directly 
as fuel for spermatogonia, or indirectly for lactate production to 
spermatocytes and spermatids by Sertoli cells (Boussouar & Benahmed 2004, 
Zysk et al. 1974). 
Lactate is the germ cell fuel, stimulates RNA and protein synthesis, and 
inhibits apoptosis (Erkkilä et al. 2002, Jutte et al. 1981). Moreover, in 1999, 
intratesticular lactate infusions recovered spermatogenesis in adult cryptorchid 
rats (Courtens & Plöen 1999). Positive effects of intratubular lactate rely on 
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Sertoli cell function, because they are capable of converting more than 90% of 
glucose to lactate and secreting it to the extracellular space (Robinson & Fritz 
1981). Sertoli cells are the major source of this anion in testis and its 
production is regulated by several mechanisms (Rato et al. 2012). Hexose 
facilitative transporters [GLUTs] incorporate glucose from the extracellular 
milieu and the presence of at least 4 isoforms [GLUT1, GLUT2, GLUT3 and 
GLUT4] have been reported in Sertoli cells (Angulo et al. 2008). The enzyme 
lactate dehydrogenase [LDH] interconverts lactate and pyruvate. 
Monocarboxylate transporters [MCTs] are responsible for lactate efflux to the 
extracellular. Both are mainly accountable for lactate provision to developing 
germ cells from Sertoli cells (Oliveira et al. 2011). Sertoli glycolytic activity is 
high; nevertheless, under adverse metabolic conditions, they are capable of 
adapting and safeguarding lactate production for germ cells. In glucose 
deprived conditions, lactate production practically does not decrease and 
Sertoli cells adapt by increasing glucose uptake and GLUT1 expression, 
decreasing GLUT3 expression and activating AMPK, PI3K/AKT and 
p38MAPK signalling pathways (Riera et al. 2009). 
Lactate production from Sertoli cells is highly regulated and numerous 
factors are responsible. Activation of AMPK by the use of an AMP analog, 
AICAR [5-aminoimidazole-4-carboxamide-2-b-d-ribonucleoside] or adding 
adenosine, stimulate glucose internalization and GLUT1, MCT4 mRNA 
expression, increasing lactate production (Galardo et al. 2007; Galardo et al. 
2010). By contrast, treatments with the steroidal sexual hormone 5α-
dihidrotestosterone [DHT] generates a significant decrease in lactate secretion 
and LDH mRNA expression despite high glucose consumption and glucose 
consumption rate (Oliveira et al. 2011). Moreover, DHT treatments redirect 
the incorporated glucose to tricarboxylic cycle conducing Sertoli cells to a 
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more efficient metabolic state (Oliveira et al. 2011; Rato et al. 2012). Follicle 
stimulating hormone [FSH], basic fibroblast growth factor [BFGF], 
triiodothyronine hormone [T3], interleukin 1α [IL-1α], insulin and insulin like 
growth factor I [IGFI] stimulate lactate production. FSH activates 
PI3K/AKT signalling, glucose incorporation and synergistically with BFGF 
induces lactate production (Meroni et al. 2004, Schteingart et al. 1999). T3 
increases lactate levels regulating GLUT1, MCT1 and 4 expressions, while IL-
1α stimulating glucose transport and the expression and activity of LDH 
(Carosa et al. 2005, Fugassa et al. 1987, Nehar et al. 1998). Insulin and IGFI 
stimulate lactate production by means of an increment of glucose transport, 
observed as an increase in a glucose analog (2-deoxyglucose) incorporation 
(Oonk et al. 1989). By contrast, cultured cells in the absence of insulin present 
altered glucose consumption and lactate production, a decrease in GLUT3, 
LDHA and MCT4 expression while GLUT1 expression increases as an 
adaptive response (Oliveira et al. 2012). 
Despite glucose being principal source for lactate production, it is not the 
main metabolite for ATP production because Sertoli cells stay viable in the 
absence of glucose (Xiong et al. 2009). Other proposed ways to obtain energy 
are catabolism of glycogen and aminoacids. Glycogen and enzymes involved 
in their synthesis and degradation have been described in Sertoli cells 
(Slaughter & Means 1983, Villarroel-Espíndola et al. 2013). In embryonic 
stages, pre-Sertoli cells use glycogen as an energy source to maintain SOX9 
expression, a fundamental process for testiculogenesis (Matoba et al. 2005, 
2008). During postnatal stages, there is only one report about glycogen 
metabolism in rat Sertoli cells, which described that less than 2% of 
incorporated glucose is converted to glycogen (Robinson & Fritz 1981). In 
mice testis, glycogen synthase is more active during the first 5 postnatal days, 
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where mostly Sertoli cells compose seminiferous tubules (Villarroel-Espíndola 
et al. 2013). Likewise, in immature rat testis FSH activates glycogen 
phosphorylase that immunolocalized to cytoskeletal associated structures in 
Sertoli cells (Slaughter & Means 1983). On the other hand, rat Sertoli cells can 
oxidize alanine, leucine, valine and glutamine to CO2 to obtain energy, where 
glucose and palmitic acid are capable to regulate their metabolism (Kaiser et 
al. 2005). 
From all the cells that compose the testis, Sertoli cells are the ones that 
produce more ATP (Xiong et al. 2009). ATP production comes principally 
from phagocytosis of apoptotic germ cells and residual bodies to obtain lipids, 
which are the source for ATP via beta-oxidation (Xiong et al. 2009). This 
process was demonstrated by blocking glycolysis with 2-DOG, where ATP 
levels are maintained. When blocking beta-oxidation with an inhibitor of the 
long chain acyl-CoA dehydrogenase (2-mercaptoacetate), ATP levels decrease 
drastically (Xiong et al. 2009). In addition, rat Sertoli cells cultured in presence 
of different palmitate concentrations, show that they can oxidize it to CO2, 
ketonic bodies, and fatty acids, the last ones being the main energy source for 
these cells (Jutte et al. 1985). This indicates that in this biological context beta-
oxidation of lipids acquired from phagocytosed apoptotic germ cells and 
residual bodies is the main pathway to obtain ATP by Sertoli cells. 
Thereby, Sertoli cell metabolism is highly regulated by several hormones 
and growth factors, is focused in lactate production through glycolysis as 
energetic fuel for developing germ cells, and generates its own energy from 
apoptotic germ cells and residual bodies to obtain ATP via beta-oxidation, 
without discarding glycogen and aminoacid metabolism contribution. 
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1.5 Metabolic Enzymes as RNA Binding Proteins.  
Metabolic enzymes are classically described to have specifics roles related 
to different anabolic or catabolic processes, which are useful for cell survival 
and function. In many studies they are referred to as “housekeeping genes”, 
but in the last decades new roles have been reported that link the intermediary 
metabolism and the regulation of gene expression (Cieśla 2006, Hentze & 
Preiss 2010). Enzymes involved in different processes like tricarboxylic acid 
cycle, glycolysis, pentose phosphate cycle, fatty acid metabolism, and 
pyrimidine synthesis, have been shown to bind RNA, and leading edge 
technology is being used to demonstrate this relationship (Castello et al. 
2012a, Cieśla 2006, Kim & Dang 2005). 
The most studied enzyme that binds RNA is the cytosolic aconitase, also 
known as iron responsive protein 1 [IRP-1]. This enzyme catalyses the 
isomerization of citrate to isocitrate in the tricarboxylic acid cycle and binds to 
iron responsive RNA elements [IREs] located in mRNA untranslated regions 
[UTRs] of iron metabolism related genes (Beinert & Kennedy 1993, Kaptain 
et al. 1991). In iron-replete cells, a 4Fe-4S cluster inserts to the bifunctional 
enzyme allowing its catalytic activation, being inactive as an IRE binding 
protein (Hentze & Kuhnt 1996). While in iron-deficient cells, the enzyme 
without the cluster leaves the IRE-binding site accessible allowing the binding 
to IREs. This permits the regulation and stability of mRNAs encoding 
functions in iron homeostasis and related processes (Hentze & Kuhnt 1996, 
Wallander et al. 2006). In the same way, all three enzymes of the thymidylate 
synthesis cycle [thymidylate synthase [TS], serine hydroxymethyl-transferase 
[SHMT] and dihydrofolate reductase [DHFR]] regulate the translation of their 
own mRNAs among others (Chu & Allegra 1996, Chu et al. 1991, 1993; Liu et 
al. 2000). These enzymes bind to 5`UTR or coding regions and the binding is 
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negatively regulated by their substrates, for the case of TS, deoxyuridyn-
monophosphate [dUMP] and dihydrofolate [DHFP] (Chu et al. 1993, Liu et 
al. 2002). Another enzyme described to bind RNAs is glyceraldehyde-3-
phosphate dehydrogenase [GAPDH], which metabolically catalyses the 
conversion of glyceraldehyde-3-phosphate to 1,3-biphosphoglycerate using 
NAD+ as cofactor. Non-glycolytic activities have been attributed to GAPDH 
including DNA binding, helicase activity, and DNA repair, showing that this 
enzyme has broad features regarding nucleic acid interaction (Karpel & 
Burchard 1981, Meyer-Siegler et al. 1991, Perucho et al. 1977). AU-rich 
elements [AREs] are involved in the turnover and translation of numerous 
mRNAS and GAPDH was discovered as a new AREs binding protein 
[ARBP]. GAPDH/RNA interaction rely specifically in its NAD+ binding 
region [Rossman Fold], thus depending on NAD+ concentrations to act as a 
glycolytic enzyme or an ARBP (Nagy & Rigby 1995, Nagy et al. 2000). Also, in 
vivo studies have shown that GAPDH interacts with RNAs, as part of 
ribonucleoprotein particles in human parainfluenza virus-infected cells (De et 
al. 1996).  
Another glycolytic enzyme like lactate dehydrogenase [LDH], which 
catalyses the interconvertion of pyruvate and lactate with concomitant 
oxidation of NADH to NAD+, have been identified to bind mRNAs. LDH 
acts as an ARBP interacting with granulocyte-macrophage colony-stimulating 
factor [GMCSF] mRNA 3`UTR regulating its translation (Pioli et al. 2002). 
The binding occurs in the NAD+-binding region and the localization in 
translationally active polysomes depends on the RNA binding capacity, which 
is supported by the complex with the RNA binding proteins AUF1 and 
Hsp70 (Pioli et al. 2002). In addition to GAPDH and LDH, glucose-6-
phosphate dehydrogenase [G6PDH] binds specifically to various regions of 
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the GLUT1 mRNA, indicating the relevance of this mechanism to control the 
rate-limiting step in glucose utilization (McGowan & Pekala 1996). Similarly, 
phosphoglycerate kinase [PGK] binds to the coding region of urokinase-type 
plasminogen activator receptor [uPAR] mRNA, downregulating its expression 
affecting the proliferation and migration of human bronchial epithelial cells 
(Shetty et al. 2004).  
Glycogen synthase can be associated to RNAs because few studies have 
shed light on this connection. A proteomic survey of endoplasmic reticulum 
[ER] function in the liver shows the differences between rough and smooth 
ER protein components. The hepatic isoform of glycogen synthase [LGS] was 
found as an enriched component of rough endoplasmic reticulum but not in 
the smooth endoplasmic reticulum (Song et al. 2010). In another 
approximation, using a proteomic multidimensional protein identification 
technology, muscle isoform of glycogen synthase [MGS] was identified as a 
component of ribosomes (Fuchs et al. 2011). As a non-ribosomal protein, 
MGS was associated with translationally active ribosomes in HeLa cells, and 
specifically the phosphorylated form in Serine640 [pSer640-MGS] (Fuchs et 
al. 2011). MGS depletion in HeLa cells resulted in a loss of polysomes, 
corroborated by a small, but not significant, decrease in [35S]methionine 
incorporation on global cellular translation (Fuchs et al. 2011). This suggests 
that the enzyme might regulate the translation of only a subset of mRNAs. 
Our laboratory described the functional presence of malin, an E3 
ubiquitin ligase, and laforin, a dual phosphatase, promoting the 
polyubiquitination of MGS in Sertoli cells through the interaction with malin-
ring domain in the Sertoli cell line 42GPA9 (Villarroel-Espíndola et al. 2013). 
Malin has been described to be recruited to processing bodies, co-localizing 
with different markers like AGO2, Dcp1, Xrn1, and GW182 in HeLa cells 
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(Singh et al. 2012). Malin regulates the recruitment of the mRNA decapping 
enzyme Dcp1 by promoting its polyubiquitination and degradation, and 
playing a pivotal role in microRNA-mediated gene silencing by processing 
bodies (Singh et al. 2012). Additionally, laforin, which interacts indirectly with 
MGS through malin-ring domain, was reported to be a ribosome-associated 
protein, being immunoprecipitated in polyribosomes fractions (Ganesh et al. 
2000). 
 
1.6 Problem statement 
The present data indicates that glycogen content in mature mice testis is 
scarce. Nevertheless, the amount of detected glycogen synthase does not 
correlate with glycogen content in Sertoli cells [unpublished results from our 
laboratory]. Additionally, it was observed that in lithium treated Sertoli cells 
MGS is accumulated in only one or two cytoplasmic granules. This behaviour 
is very different in muscle and adipose tissue, where lithium produces many 
glycogen particles, indicating that MGS acts differently in Sertoli cells. 
Furthermore, the reported interaction of the hepatic isoform with rough ER, 
the cosedimentation of pSer640MGS with elongating ribosomes, and the 
interaction of Malin and Laforin, which in turn interact with MGS, with 
ribonucleoprotein complexes, indicate that MGS could effectively interact 
directly or indirectly with ribonucleoprotein complexes and regulate, by some 
unknown mechanism, the expression of several mRNAs. These antecedents 
constitute a motivating challenge to demonstrate that MGS acts as an RNA 
binding protein. By the analysis of MGS relationship with mRNA expression 
regulation, it is possible to unveil a putative novel function of this enzyme in 
mice Sertoli cells. 
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2. Hypothesis 
 
Muscle glycogen synthase is predominantly inactive and has a new role as an 
RNA binding protein in mice Sertoli cells  
 
 
2.1 General Objectives 
 
1. To demonstrate the activity state of muscle glycogen synthase in Sertoli 
cells. 
2. To demonstrate glycogen synthase interaction with RNAs in Sertoli 
cells 
 
2.1.1 Specific Objective for General Objective 1 
 
• To evaluate muscle glycogen synthase expression, localization, 
phosphorylation state and function in Sertoli cells obtained from 
primary cell cultures and cell line 42GPA9. 
 
2.1.2 Specific Objective for General Objective 2 
 
• To evaluate the interaction of muscle glycogen synthase with RNAs 
and different RNA binding proteins. 
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3. Materials and Methods 
 
 
3.1 Materials 
 
3.1.1 Reagents 
The following reagents were acquired from Winkler Ltda.: Tris 
[hydroximethyl] aminomethane, sodium dodecyl sulfate [SDS], ammonium 
persulfate, glycerol, sodium bicarbonate, phenylmethanesulfonylfluoride 
[PMSF], lithium chloride, lithium carbonate, glycine, dimethylsulfoxide 
[DMSO], bromophenol blue, sodium chloride and sodium fluoride. 
Calbiochem: ß-mercaptoethanol. Merck, Darmstadt, Germany: sodium 
hydroxide, potassium chloride, formaldehyde solution 37%, agar-agar, 
hydrogen chloride, methanol, ethanol, tetramethylethylenediamine [TEMED], 
acrylamide, bis-acrylamide, isopropanol and chloroform. US biological, 
Swampscott, MA, USA: Ehylenediaminetetraacetic acid [EDTA], ampicillin 
sodium salt. Thermo Fisher Scientific: Hyclone classical powdered media 
DMEM F12 [SH30004.04], Hyclone fetal bovine serum FBS [SH30396.03], 
Hyclone trypsin [SH30236.01], dimethyl pimelimidate*2HCl [21666], 
pageruler plus prestained protein ladder [26619], Halt protease inhibitor 
cocktail 100X [87786], ECL Western blotting substrate. Sigma-Aldrich: 
Sodium deoxycholate, D-glucose, 2-mercaptoethanol, tween-20, 
triethanolamine, sucrose, collagenase crude type IA [C2674], Hyaluronidase 
type V [H6254], deoxyribonuclease I [DN25], Hanks` balanced salt solution, 
monoclonal anti-α-tubulin antibody produced in mouse [T5168]. Life 
Technologies, Carlsbad, USA: Trizol reagent [15596018], RNAseout 
recombinant RNAse inhibitor [10777019], dynabeads protein A [10002D], 
! 23!
Gibco antibiotic-antimycotic 100X [15240-062], Opti-MEM I® reduced 
serum media [31985-062], Lipofectamine® 2000 transfection reagent [11668-
019], SYBR ® SAFE DNA stain, alexa fluor 488 donkey anti-mouse IgG [A-
21202], alexa fluor 488 donkey anti-rabbit IgG [A-21206], alexa fluor 568 goat 
anti-mouse IgG [A-11004], alexa fluor 633 goat anti-rabbit IgG [A-21070] and 
4`,6-diamidino-2-phenylindole, dihydrochloride [DAPI]. MO BIO 
Laboratories: LB Broth powder growth media. Dako: Fluorescent mounting 
medium. Promega: RQ1 RNase-free DNase [#M6101], 1 kb DNA ladder. 
Bio-Rad: Bio-Rad protein Assay, IPG strips 7 cm. pH range 4-7. New 
England Biotechnologies: Lambda protein phosphatase [NEB.P0753S]. Cell 
Signaling: anti-phospho-glycogen synthase [Ser640] antibody produced in 
rabbit [#3891], anti-glycogen synthase 15B1 produced in rabbit [#3886], 
pS640MGS and MGS 3886 respectively in this work. Abcam: anti-
Ago2/eIF2C2 antibody produced in rabbit [ab32381]. Santa Cruz 
Biotechnology: normal rabbit IgG [sc-2027], anti-glycogen synthase 1 GS-7H5 
antibody produced in mouse [sc-81173], puromycin [sc-108071], Polybrene® 
[sc-134220]. Millipore: anti-glycogen synthase CT antibody produced in rabbit 
[04-357], ctMGS in this work. GeneON: Maximo Taq DNA Polymerase, 
MMLV Reverse Transcriptase, 4 dNTP´s set. 
 
3.1.2 Animals used for experimentation 
Experimental procedures were performed using C57BL6 mice, 
maintained (housing, handling, care and processing) in accordance with the 
“Rules for animal investigation” dictated by the Animal Usage in Research 
Committee of the Universidad Austral de Chile. The sleep and wakefulness 
cycles, as well as, alimentation and ad libitum drinking water were always 
maintained. Animal slaughtering was also performed under the rules of the 
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Animal Usage in Research Committee of the Universidad Austral de Chile 
avoiding animal suffering and pain. Animal remains were eliminated under 
biosafety instructions of the aforementioned committee. 
 
3.1.3 Equipment 
Laboratory pH meter inoLab pH720; microfuge Sigma 1-14; centrifuge 
Sigma 2-16PK; ultra turrax IKA T10 basic; revolver rotator Labnet; waving 
plataform Heidolph polymax 1040; magnetic stirrer IKA rh basic 2; precision 
balance Sartorius TE612; analytical balance A&D GR-200; rocking incubator 
Zhicheng ZHWY-100B; thermoregulated bath Oilbath ONE; 
chemiluminiscence documentation system Syngene G:BOX chemi; gradient 
thermocycler Eppendorf Mastercycler gradient; CO2 incubator Nuaire DH 
Autoflow; biological safety cabinet class II, type A2 Nuaire UN-425-600-E; 
UV-Vis spectrophotometer NanoDrop 2000; confocal microscope 
OLYMPUS Fluoview FV1000; inverted microscope OLYMPUS CKX41; 
ultrasonic bath  Elmasonic S30H; sonicator Bioruptor®; electrophoresis 
system mini-protean® tetra cell; electrophoretic transfer cell system mini 
trans-blot®; fluorescence UV transiluminator InGenius Syngene; magnetic 
rack for microcentrofuge tubes MagnaRack TM Invitrogen; Hitachi high-
speed refrigerated centrifuge CR22 GIII.  
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3.2 Methods 
 
 
3.2.1 Cell cultures  
 
3.2.1.1 Sertoli 42GPA9 cell line culture 
Sertoli 42GPA9 cell line was widely validated by the group that isolated 
them, Georges Pontis and Dominique Segretain at the Université Paris 5, 
Paris, France (Bourdon et al. 1998). Cells were grown on supplemented 
DMEM-F12 with 10% (v/v) fetal bovine serum [FBS], L-glutamine 2mM, 
penicillin 50 U/mL, streptomicyn 50 mg/mL and fungizone 50ng/mL at 
37ºC and 5% CO2 (Bourdon et al. 1998). Cells at 80% confluence were 
detached using 0.25% trypsin-5 mM EDTA. 
 
3.2.1.2 Mice primary Sertoli cell cultures 
Sertoli cells were obtained from 30-40 days old C57BL6 male mice as 
described previously (Anway et al. 2002), with modifications. Testis were 
removed, decapsulated and placed in 1X Hanks. The seminiferous tubules 
were dispersed, not fragmented, in a collagenase solution [10mL, 0.5 mg/mL] 
in Hanks 1X at 34ºC for 15 minutes, shaken at 80 oscillations/min, and 
allowed to settle. The supernatant was decanted and the tubules were washed 
three times with Hanks 1X. The tubules were further incubated in a trypsin 
solution [10 mL, 0.5 mg/mL] in Hanks 1X at 37ºC without shaking. Next, 
tubules were washed two times with Hanks 1X, and the third wash was made 
with Hanks 10% [v/v] FBS to inhibit trypsin and allowed to settle for 2 
minutes. To separate Sertoli and germ cells, tubules were incubated with a mix 
of enzymes [10 mL, 1 mg/mL collagenase, 2 mg/mL hyaluronidase and 0.4 
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mg/mL DNAse I] and 1% FBS in Hanks 1X at 34ºC for 40 minutes, shaken 
at 80 oscillation/min. Sertoli cell preparation was centrifuged to pellet the 
cells at 500 Xg for 3 minutes, and then washed 3 times with Hanks. It was 
important to disperse cell clumps to separate the cells. The last wash was 
made with supplemented DMEM-F12 [as is described in 3.2.1.1] in the same 
conditions. Other protocols were not used because they comprise more steps, 
including hypotonic treatments to destroy germ cells that decrease the number 
of isolated Sertoli cells. Finally, the cell mixture to the plate and washed them 
10 times per day with sterile PBS. Only Sertoli cells were found attached to 
the plate, while remaining dead germ cells were discarded during daily washes. 
 
3.2.2 Protein extraction 
Both for polyacrylamide gel electrophoresis and inmunoprecipitation 
assays, protein extracts were obtained in RIPA buffer [150 mM NaCl, 1% 
Triton-X100, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris-HCl, pH 
8.0] supplemented with a cocktail of proteases, phosphatase inhibitors [10mM 
NaF, 1mM inorganic pyrophosphate, 25 nM okadaic acid, 2 mM sodium 
orthovanadate]. RNAse inhibitor was added only for RNA 
inmunoprecipitations. For tissue protein extraction, 5 mg of tissue was 
homogenised with ultra-turrax in supplemented RIPA buffer. In the case of 
cell cultures, the supplemented buffer was directly added to the plates, which 
were scraped to detach the cells. Next, the cell suspension was sonicated twice 
for 5 minutes on ice, vortexing between each sonication, and then the extracts 
were passed 8 times through a 25G needle. Protein concentration was 
quantified using Bio-Rad protein Assay based on the method of Bradford.  
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3.2.3 Protein immunodetection and cellular immunolocalization  
 
3.2.3.1 Polyacrylamide gel electrophoresis (SDS-PAGE) 
Protein extracts were resuspended in sample buffer [62.5 mM Tris-HCl 
pH 6.8, 25% glycerol, 12.5% ß-mercaptoethanol, 0.025% bromophenol blue] 
and heated at 95ºC for 5 minutes and then loaded into the gel. All the 
preparations were run in 8% polyacrylamide gels. The stacking and spacer gel 
was prepared from a 29.2:0.8 acrylamyde:bis-acrylamide stock solution. The 
spacer gel was prepared to a final concentration of 8% containing 375 mM 
Tris-HCl [pH 8.8], 0.1% SDS, 0.04% ammonium persulfate and 0.03% 
TEMED. The stacking gel was prepared to a final concentration of 5% 
containing 125 mM Tris-HCl [pH 6.8], 0.1% SDS, 0.09% ammonium 
persulfate and 0.06% TEMED. Gel electrophoresis was performed at 100 
Volts during approximately 3 hours in running buffer [25 mM Tris-HCl, 190 
mM glycine, 0.1% SDS) until the dye front reached the bottom of the gel. 
 
3.2.3.2 Western Blot 
Electrophoretically separated proteins were transferred to a PVDF 
membrane previously activated for 30 second with 100% methanol. The 
membranes were blocked with 5% non-fat dry milk in TBS-T for at least 45 
minutes. Then, the blocked membranes were incubated with a primary 
antibody overnight at 4ºC with constant rotation. Dilution of all the primary 
antibodies was 1:1000, except for tubulin that was used in 1:5000. Next, the 
membranes were washed 3 times with TBS-T and incubated with the 
secondary antibody, conjugated to peroxidase, for 1 hour at room 
temperature. Finally, luminescent signal was detected using the 
chemiluminescent substrate for peroxidase, ECL, and visualized by 
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chemiluminescence documentation system, Syngene G:BOX chemi. The 
secondary antibodies were diluted 1:5000 in TBS-T. The obtained bands were 
statistically evaluated by Student’s t-test or non-parametric statistical analyses 
using Prism version 5.0 for Mac OS X. 
 
3.2.3.3 Indirect immunofluorescence in Sertoli cells 
Cultured Sertoli cells, from the cell line 42GPA9 and primary cultures, 
were grown in circular coverslips to 50% confluence and prior to fixation 
were washed 3 times with ice cold PBS to discard any rest of culture media, 
and fixed with 4% formaldehyde in PBS for 15 minutes with moderate 
shaking. To permeabilise Sertoli cells, formaldehyde was discarded and 
immediately -20ºC methanol was added for 10 minutes with shaking at room 
temperature. Next, 5% bovine serum albumin in TBS was used to block for 1 
hour with soft agitation at room temperature. Primary antibodies were 
prepared in the same blocking solution at different concentrations, incubated 
overnight at 4ºC and then washed 3 times with TBS-T. Fluorescent secondary 
antibodies, in addition with the nuclear dye [DAPI or propidium iodide], were 
also prepared in TBS in a concentration of 1:300, incubated 2 hours at room 
temperature and washed 3 times with TBS-T. Finally, the cells in coverslips 
were mounted in glass slides using 5 uL of DAKO fluorescent mounting 
medium per cover. The immunofluorescence signals were analysed using the 
confocal microscope OLYMPUS Fluoview FV1000.  
 
3.2.4 Electronic microscopy 
Transmission electronic microscopy analyses were performed with the 
collaboration of Gernot Längst in the University of Regensburg, Regensburg, 
Germany. Cultured 42GPA9 cells on 12 well plates were fixed with 
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glutaraldehyde 2.4% in 100 mM phosphate buffer at pH 7.0, for 2 hours at 
4ºC, and then washed 2 times for 15 minutes with the same buffer. The 
samples were post-fixated with 1% osmium tetroxide in 100 mM phosphate 
buffer at pH 7.0, for 2 hours at 4ºC, and then washed again 3 times with the 
same buffer. Next, the cells were dehydrated as follows: 50% [v/v] ethanol for 
10 minutes, 70% [v/v] ethanol for 10 minutes, 90% [v/v] ethanol for 10 
minutes, 96% [v/v] ethanol for 10 minutes, 100% [v/v] ethanol 2 times for 5 
and 10 minutes, and 100% [v/v] acetone 2 times for 5 and 10 minutes. After 
dehydration, cells were included in Araldite by incubating with 
acetone/Araldite 1:1 [v/v] for 1 hour, and then only with the resin for 4 
hours. To polymerise the resin, cells were baked at 56ºC for 12 hours in the 
12 well plates. Finally, the resin blocks with the cells were ultra-sectioned and 
collected in grids to stain the anionic and cationic components with 5% uranyl 
acetate during 15 minutes, and 0.4% lead citrate for 3 minutes. 
 
3.2.5 Glycogen synthase activity  
Glycogen synthase activity and glycogen quantification assays were 
performed in the Laboratory of Metabolic Engineering and Diabetes directed 
by Joan Guinovart PhD, in the Institute for Research in Biomedicine IRB 
Barcelona, Barcelona, Spain. The assays were done in AdGFP and AdPTG 
transduced Sertoli cells as was described in Vilchez et. al. 2007, and in 24 
hours treated Sertoli cells with 90 mM lithium chloride. 
 
3.2.5.1 Measurement of Glycogen synthase activity 
Determination of glycogen synthase activity was assayed as described 
previously (Thomas et al. 1968, Vilchez et al. 2007). Frozen Sertoli cells grown 
in 100 mm diameter plates were scraped and homogenised with a 25G needle 
! 30!
in a buffer containing protease and phosphatase inhibitors. To normalize the 
activity values, protein concentration of each sample was determined 
following Bradford method using the Bio-Rad protein assay reagent. The 
activity was measured in the absence or presence of the allosteric activator 
G6P [6.6 mM]. In the presence of G6P, the measured activity represents the 
total activity of the enzyme, while the measured activity in the absence of G6P 
represents only the intrinsically active enzyme. For this reason, the –
G6P/+G6P activity ratio represents the activation state of the enzyme, where 
values below 0.1 indicate a fully inactive enzyme whereas those above 0.7 are 
equivalent to complete activation (Guinovart et al. 1979). 
 
3.2.5.2 Glycogen quantification 
Glycogen content quantification was performed as described previously 
(Chan & Exton 1976). Sertoli cells grown on 100 mm diameter plates were 
frozen with liquid nitrogen, scrapped on ice with 200 uL of 30% KOH, and 
transferred to a 1.5 mL tube. Then, cell extracts were heated 15 minutes at 
100ºC and all the volume was added over a Whatman filter paper. Each 
sample volume was annotated for calculations and 5-10 uL of each extract 
was used for protein quantification. Once the samples were absorbed in the 
filter paper, they were washed with 66% cold ethanol [stored at -20ºC] for 10 
minutes shaking. At this concentration only glycogen precipitates in the paper. 
Two more washes were made with 66% cold ethanol for 30 minutes each with 
shaking. Next, the papers were incubated in acetone for 5 minutes to 
eliminate ethanol and then dried at room temperature. Dried papers were 
transferred to a 1.5 mL tube with 1 mL of 0.5 mg/mL amyloglucosidase in 
100 mM sodium acetate buffer pH 4.8, and incubated at 37ºC for 90 minutes. 
During this step amyloglucosidase hydrolyse glycogen to glucose molecules. 
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Finally, glucose quantity was determined spectrophotometrically by measuring 
the absorbance [340 nm] of reduced NADH generated from the coupled 
reaction hexokinase/G6PDH that is directly proportional to glucose amounts. 
 
Reaction: 
Hexokinase 
D-Glucose + ATP   !  Glucose-6-P + ADP 
 
G6PDH 
                   Glucose-6-P + NAD+ !  gluconate-6-P+ NADH+ H+ 
 
Calculation: 
 
glucose concentration (mg/dL) * 9000                  = ug glycogen/mg protein 
sample volume (uL) * protein concentration (ug/uL) 
 
9000= factor from conversion of 1 ug of glycogen to glucose [0.9], and the 
conversion from the other units to get to ug glycogen/mg protein. 
 
3.2.6 RNA immunoprecipitation and microarray profiling  
The experiments were performed in the Laboratory of Translational 
Control of Cell Cycle and Differentiation directed by Raúl Mendez PhD, 
while the Biostatistics/Bioinformatic Unit achieved the bioinformatics 
analysis, both at the Institute for Research in Biomedicine, IRB Barcelona, 
Barcelona, Spain. 
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3.2.6.1 Crosslinking 
Sertoli cells were grown until 80% confluence in 100 mm diameter 
plates and washed twice with cold PBS to eliminate any remain of culture 
medium. For crosslinking, the cells were incubated for 10 minutes with 1% 
formaldehyde in PBS at room temperature with gentle agitation. Then, 1 M 
glycine was added to the plates to obtain a final concentration of 0.25 M 
glycine and incubated for 5 minutes with soft agitation at room temperature 
to stop the crosslinking. Cells were washed twice with PBS and then the 
extracts were obtained as described in 3.2.2. 
 
3.2.6.2 Antibody covalent binding to Dynabeads  
Dynabeads [50 uL] were transferred to a 1.5 mL tube, washed twice 
with and resuspended in 600 uL PBS. The same amount of each antibody 
used [rabbit IgG, anti-ctMGS, anti-pSer640MGS, anti-Ago2] was added to 
dynabeads suspension and incubated for 2 hours on a wheel rotator at room 
temperature. Next, the suspension was washed once with PBS, twice with 0.2 
M triethanolamine pH 8.2, and then incubated with 1 mL of 20 mM dimethyl 
pimelimidate*2HCl [DMP] in triethanolamine for 30 minutes on a wheel 
rotator at room temperature. DMP was used to induce the covalent binding 
of the antibodies to the protein A Dynabeads. The reaction was stopped with 
2 washes with 0.05 M glycine for 5 minutes at room temperature. The 
preparation was washed 3 times with PBS and then incubated with 600 uL of 
0.1 M citric acid pH 3.0 for 2 minutes on a wheel rotator at room temperature 
to remove free antibodies. Finally, coupled antibodies to protein A Dynabeads 
were washed twice with lysis buffer [RIPA] and resuspended with 500 uL of 
the same buffer supplemented with protease inhibitors. 
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3.2.6.3 Immunoprecipitation 
Dynabeads protein A [25 uL] were washed twice with PBS and then 
used for pre-clearing approximately 500-600 uL of cellular extract [from 
3.2.2]. Pre-clearing was performed by incubating the mixture for 30 minutes 
at 4ºC on a wheel rotator. An aliquot of 50 uL of the cellular extract was taken 
before making the pre-clear as an input for the Western blot, while 200 uL of 
the input were saved for total RNA extraction. The antibodies conjugated to 
protein A Dynabeads were incubated with the pre-cleared cellular extracts 
during 4 hours on a wheel rotator at 4ºC, to immunoprecipitate the desired 
proteins depending on the used antibody. After the 4 hours, magnetic protein 
A Dynabeads were concentrated using a magnetic rack [MagnaRack] for 1.5 
mL tubes, and an aliquot of 50 uL of the unbounded extract was taken from 
each sample as “unbound” for the Western blot. The rest of the unbounded 
extract was discarded and the magnetic beads were washed 10 times with 
RIPA buffer. After the last wash, the immunoprecipitated extract with the 
magnetic beads was resuspended with 1 mL of RIPA, where 300 uL were 
used to verify if the immunoprecipitation was successful by Western blot. The 
remaining 700 uL were used for RNA extraction. The immunoprecipitated 
fraction for Western blot, as well as, input and unbound extracts were 
resuspended in 30 uL of sample buffer. Heated at 95ºC for 5 minutes, briefly 
pelleted by a spin down, and then only the aqueous portion was loaded on the 
gel, while the magnetically concentred beads were discarded. 
 
3.2.6.4 Crosslinking reversion, RNA extraction and mRNA expression 
profiling 
Input and immunoprecipitated extracts for RNA purification were 
firstly treated with 70 ug of proteinase K for 1 hour at 37ºC. Next, to revert 
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the crosslink, samples were heated to 65ºC for 1 hour. Then, RNA extraction 
was performed by the phenol-chloroform method using the Trizol reagent as 
described in http://www.dnaarrays.org/D_SmallTrizol.pdf. Briefly, the RNA 
was precipitated with isopropanol, washed with 75% ethanol, re-precipitated 
with ethanol at -20ºC to remove remaining phenol, and washed again with 
75% ethanol. The extracts were finally treated with RNAse free DNAse and 
quantified to assess the concentration and quality of the RNAs with a 
NanoDrop 2000. Purified RNAs were used to perform an mRNA profiling by 
using an Affymetrix expression array for mouse genome. 
 
3.2.6.5 Profiling data analysis 
Data for microarray analysis was obtained from a single RNA 
inmunoprecipitation assay. For this reason it was necessary to normalize 
probe intensities, because probes with minor intensities tend to produce 
higher fold changes. To produce corrected fold changes, the Bioconductor 
(Gentleman et al. 2004) function “rma” from the oligo package was used to 
perform an RMA normalization (Irizarry et al. 2003). The background was 
corrected, and a quantile normalization and median polish summarization was 
performed. The summarization was done from the probe level to the probe 
set level. Fold changes were corrected for probe intensity biases. Gam 
approximation was used to estimate and remove biases in mean and deviation. 
A bayesian posterior probability model was fitted to the adjusted fold 
changes to compute posterior probabilities in order to identify significantly 
differentially expressed genes with a false discovery rate of 5% (Rossell et al. 
2008). 
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3.2.7 Amplification of studied sequences  
 
3.2.7.1 RNA extraction and complementary DNA synthesis 
Total RNA extraction from tissue and cultured Sertoli cells was made 
using the Trizol reagent according to the manufacturer instructions. Next, the 
preparations were treated with the RQ1 RNAse-free DNAse and quantified 
using NanoDrop 2000. For cDNA synthesis, 1 ug of RNA was 
retrotranscribed following the MMLV reverse transcriptase [GeneOn 105-
100] instructions, to a single strand of complementary DNA [cDNA]. A 
negative control, to verify any contamination for retrotranscription, a reaction 
mix without template was used. 
 
3.2.7.2 Polymerase chain reaction PCR 
Encoded fragments of genes of interest were obtained from previously 
synthesised cDNAs from tissue and cell RNA as described in the afore 
mentioned point. The protocol indicated by the manufacturer of Maximo Taq 
DNA polymerase was used to amplify the fragments of interest from the 
cDNA. The amplification program consisted in an initial denaturation for 5 
minutes at 94 ºC, 25 cycles of denaturation for 15 seconds at 94º C, annealing 
for 15 seconds at 55-65 ºC depending of the primers used, and extension for 1 
minute at 72º C, and a final extension of 5 minutes at 72 ºC. A negative 
control was prepared in the absence of template. The amplicons were 
analysed by 1.5% agarose gel electrophoresis in TAE buffer.  
 
3.2.8 Mass spectrometry analysis 
This assay was performed in the Laboratory of Translational Control of 
Cell Cycle and Differentiation directed by Raúl Mendez PhD, and in the Mass 
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Spectrometry Core Facility in the Institute for Research in Biomedicine, IRB 
Barcelona, Barcelona, Spain. 
Protein extracts of Sertoli cells, obtained as described on 3.2.2, were 
used for corroborate the inmunoprecipitation of glycogen synthase. The 
enzyme was immunoprecipitated with 3 different antibodies [pSMGS, MGS 
3886 and ctMGS] as described in 3.2.6.3, and the immunoprecipitated 
extracts were run on a PAGE-SDS gel. The corresponding band for glycogen 
synthase, by size [≈ 85 kDa], was excised and samples were digested in-gel 
with trypsin and resuspended in 50 uL 1% formic acid. 4 uL of each sample 
were loaded to a 180 µm x 2 cm C18 Symmetry trap column [Waters] at a 
flow rate of 15 µl/min using a nanoAcquity Ultra Performance LCTM 
chromatographic system [Waters Corp., Milford, MA]. Peptides were 
separated using a C18 analytical column [BEH130™ 75 mm x 10 cm, 1.7 µm, 
Waters Corp.] with a 80 min run, comprising three consecutive steps with 
linear gradients from 1 to 35% B in 60 min, from 35 to 50% B in 5 min, and 
from 50 % to 85 % B in 3 min, followed by isocratic elution at 85 % B in 10 
min and stabilization to initial conditions [A= 0.1% FA in water, B= 0.1% FA 
in CH3CN]. The column outlet was directly connected to an Advion TriVersa 
NanoMate [Advion] fitted on an LTQ-FT Ultra mass spectrometer [Thermo]. 
The mass spectrometer was operated in a data-dependent acquisition [DDA] 
mode. Survey MS scans were acquired in the FT with the resolution [defined 
at 400 m/z] set to 100,000. Up to six of the most intense ions per scan were 
fragmented and detected in the linear ion trap. The ion count target value was 
1,000,000 for the survey scan and 50,000 for the MS/MS scan. Target ions 
already selected for MS/MS were dynamically excluded for 30s. Spray voltage 
in the NanoMate source was set to 1.70 kV. Capillary voltage and tube lens on 
the LTQ-FT were tuned to 40 V and 120 V. Minimal signal required to trigger 
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MS to MS/MS switch was set to 1000 and activation Q was 0.250. The 
spectrometer was working in positive polarity mode and singly charge state 
precursors were rejected for fragmentation. At least one blank run before each 
analysis was performed in order to ensure the absence of cross contamination 
from previous samples. 
A database search was performed with Proteome Discoverer software 
v1.3 [Thermo] using Sequest search engine and SwissProt database [rodent 
release 12_05]. Search parameters included trypsin enzyme specificity, 
allowing for two missed cleavage sites, carbamidomethyl in cysteine as static 
modification and methionine oxidation as dynamic modifications. Peptide 
mass tolerance was 10 ppm and the MS/MS tolerance was 0.8 Da. Peptides 
with a q-value lower than 0.1 were considered as positive identifications with a 
high confidence level.  
 
3.2.9 Two-dimensional gel electrophoresis of immunoprecipitated MGS 
Protein extracts of muscular, brain and Sertoli 42GPA9 cells were 
obtained using homogenization buffer [10 mM Tris-HCl pH 7.0, 150 mM KF, 
15 mM EDTA, 0.6 M sucrose, 15 mM 2-mercaptoethanol, 10 µg/ml 
leupeptin, 10 µg/ml aprotinin, 10 µg/ml pepstatin, 1 mM benzamidine, 1 mM 
sodium orthovanadate, 25 nM okadaic acid and 1 mM phenylmethylsulfonyl 
fluoride] as was described in 3.2.5.1. From total protein extracts, MGS was 
immunoprecipitated using the antibody against the C-terminal end of the 
enzyme as was described in 3.2.6.3. The pulled down proteins were 
precipitated overnight with acetone [4:1 acetone:sample] at -20ºC, and then 
rehydrated with 2D buffer [8M urea, 20mM DTT, 0,5% IPG buffer]. Each 
sample was loaded on 7 cm IPG strips pH 4-7. The program for isoelectric 
focusing [IEF] was the following: active re-hydratation 15 hours/50 Volts, 
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clean I 0,25 hours/250 Volts, clean II 1 hour/1000 Volts, pre-focus 1 
hour/4000 Volts, focus 20000 Volts/hour for 8 hours and a stop phase of 
500 Volts for 2 hours. After the IEF, the strips were equilibrated for 15 
minutes in equilibration buffer [75mM Tris-HCl pH 8.8, 6M urea, 30% v/v 
glycerol, 2% w/v SDS and 0.002% bromophenol blue] supplemented with 
fresh DTT to reach a concentration of 65 mM, with a final rinse of the strips 
with the SDS/Tris-glycine running buffer. Finally, the strips were loaded and 
run in a 10% SDS-PAGE to finally visualize the immunoprecipitated proteins 
separated by IEF and molecular weight by silver staining. 
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4.Results 
 
4.1 Muscle glycogen synthase characterization in Sertoli cells 
We have recently reported the expression of the glycogen synthase 
muscle isoform in testis and that Sertoli cells are the main source for testicular 
glycogen production (Villarroel-Espíndola et al. 2013). The present work is 
focused on the characterization of MGS specifically in Sertoli cells, using 
primary cell cultures and Sertoli 42GPA9 cells as biological models.  
MGS mRNA expression was detected by semi quantitative RT-PCR, 
amplifying the complete transcript of the enzyme [≈ 1 Kb] in testis, primary 
Sertoli cells, and 42GPA9 Sertoli cells, using muscle extract as a positive 
control. The detection of MGS mRNA differs among Sertoli cells and 
testicular extracts. In testicular extracts the enzyme mRNA was barely 
detected [Figure 3A]. While in primary Sertoli and 42GPA9 Sertoli cells, the 
identification of MGS mRNA was positive. In the Sertoli cell line, the enzyme 
messenger was amplified in comparable levels with respect to the positive 
control [Figure 3A]. Likewise, Western blot analysis of MGS protein 
expression shows similar band intensities among Sertoli cells and testicular 
tissue. In testes the enzyme is hardly detectable despite the higher loading 
observed for tubulin [Figure 3B]. While both Sertoli cell models express 
similar, but not equal, levels of MGS [Figure 3B]. Apparently more enzyme 
was detected in Sertoli 42GPA9 cells in comparison with primary Sertoli cells. 
These results show that in testes, MGS is concentrated in Sertoli cells. 
Which is in line with the fact that Sertoli cells contain higher levels of 
glycogen synthase that results in larger amounts of glycogen with respect to 
germ cells (Villarroel-Espíndola et al. 2013). Thus, RT-PCR results correlate 
with Western blot where the MGS signal is almost undetectable in testes and  
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Figure 3. Sertoli cells express muscle glycogen synthase. A) RT-PCR 
analysis of cDNAs synthesized from 1 ug of RNA extracted from Muscle, 
Testis, Primary Sertoli cells and Sertoli 42GPA9 cells. Specific primers for the 
complete transcript of the MGS were designed to amplify ≈1 Kb region. 
GAPDH was used as loading control obtaining an amplicon of 104 pair bases. 
The negative control (-), was made by replacing the template for nuclease-free 
water in the reaction mix. B) Immunodetection by Western blot of MGS, 
using protein extracts of Muscle, Testis, primary Sertoli cells and Sertoli 
42GPA9 cells. A specific antibody against the C-terminal region of glycogen 
synthase [ctMGS] was used to detect a band of approximately 85 KDa that 
corresponds to the enzyme. Tubulin detection was used as loading control 
obtaining a 55 KDa band. For A) and B) Muscle RNA and protein extracts 
were used as positive controls. C) MGS localization by indirect 
immunofluorescence assay in testicular slides [left], primary Sertoli cells 
[middle] and Sertoli 42GPA9 cells [left]. MGS detection was performed using 
the same antibody as in B) in a dilution of 1:200 and a secondary Alexa-488 
donkey anti rabbit IgG in a dilution of 1:300. Nuclei were stained with TO-
PRO-3 ®. Scale bars: 20 um. 
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is higher in Sertoli 42GPA9 cells than in primary Sertoli cells [Figure 3A and 
3B]. However, it is important to notice that the expression levels of the 
enzyme in Sertoli cells and testicular extracts are considerably lower than in 
muscle.  
Next, MGS localization was analysed by confocal immunofluorescence. 
In testicular slices a dotted pattern of MGS signals across the seminiferous 
tubule was observed [Figure 3C, left]. This indicates the presence of MGS in 
all the cellular components of the tubule, from spermatogonia to spermatids 
and in Sertoli cells, in the same way as was described in (Villarroel-Espíndola 
et al. 2013). Likewise, the punctuated pattern of MGS immunofluorescent 
signals was observed homogenously distributed over the cytoplasm of primary 
and 42GPA9 Sertoli cells [Figure 3C, center and right, respectively]. 
Transduced human muscle glycogen synthase fused to GFP was 
described in a nuclear speckled pattern of muscle and adipose cells, which 
were deprived of glucose and depleted of glycogen reserves (Cid et al. 2005). 
The same report suggested MGS participation in nuclear processes. This was 
achieved by blocking MGS nuclear export to the cytoplasm with Leptomicyn 
B, co-localizing MGS nuclear speckles with a marker of Cajal bodies [p80-
coilin], and inhibiting the nuclear localization with transcription inhibitors 
(Cid et al. 2005). However, there are no reports about the nuclear localization 
of endogenous MGS in any cell type. 
Cellular fractionation of 42GPA9 Sertoli cell was performed to separate 
nuclear and cytosolic extracts [Figure 4A]. Western blot analysis incubating 
with two antibodies against MGS, were used to detect the enzyme in both 
cellular compartments. The first antibody recognizes the C-terminal region of 
MGS [ctMGS] and detects total unphosphorylated and phosphorylated forms 
of the enzyme. Meanwhile the second specifically identifies the 
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phosphorylated form in serine640 [pS640MGS]. Cellular fractionation was 
verified with tubulin and SC-35 as markers for cytosolic and nuclear extracts, 
respectively [Figure 4A]. Both MGS antibodies detected the enzyme in 
cytosolic as in nuclear extracts of Sertoli cells with different levels of intensity 
[Figure 4A]. In the cytoplasm as in the nucleus, pS640MGS detection was 
stronger in comparison with the ctMGS signal [Figure 4A], revealing that the 
phosphorylated form of the enzyme in Ser640 is present in Sertoli cell nuclei. 
Thus, for the first time, the endogenous enzyme was identified in nuclear 
extracts with two different antibodies, besides its presence in the cytoplasm. 
To confirm the results of cellular fractionation with both MGS 
antibodies, co-immunofluorescence assays were performed in primary and 
Sertoli 42GPA9 cells [Figure 4B]. Detection of total and phosphorylated MGS 
were similar in primary Sertoli cells and Sertoli 42GPA9 cells. For both Sertoli 
cell types, ctMGS fluorescent signals were homogenously distributed over the 
cytoplasm, while the nuclear localization was almost undetectable [Figure 4B, 
upper left, and lower left]. Likewise, pS640MGS was homogenously 
distributed in the cytoplasm and also in a nuclear speckled pattern [Figure 4B, 
upper right, and lower center]. For Sertoli 42GPA9 cells, the nuclear 
localization of pS640MGS was confirmed by the co-localization with the 
splicing factor SC-35 [Figure 4B, right]. Therefore, these results indicate that 
endogenous MGS, and specifically the phosphorylated form in Ser640, is 
present in both, the cytoplasm and in the nuclei of Sertoli cells. 
After the analysis of MGS expression and cellular localization, and to 
continue with the characterization of MGS, the activity rates of the enzyme 
were analysed in both Sertoli cell types. Different reports about glycogen 
content in testes describe that glycogen amounts decrease after the first post-  
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Figure 4. pS640MGS is located in the cytoplasm and nucleus of Sertoli 
cells. A) Cytoplasmic [C] and nuclear [N] extracts that were obtained by 
cellular fractionation and analysed by Western blot to detect total MGS and 
the phosphorylated form of the enzyme in Serine 640 with the ctMGS and 
pS640MGS antibodies, respectively. Tubulin detection was used as a 
cytoplasmic control, while the splicing factor SC-35 was the control for 
purified nuclear extracts. Representative images of three independent assays 
are shown. In B), MGS immunolocalization was performed in primary Sertoli 
cells [upper panels] and Sertoli 42GPA9 cells [lower panels], by using the 
same antibodies than in A). ctMGS and pS640MGS antibodies were used in a 
dilution of 1:200, while the secondary antibody Alexa-488 donkey anti rabbit 
IgG in a dilution of 1:300. SC35 was detected with an antibody dilution of 
1:250 and conjugated with an Alexa-568 donkey anti mouse IgG secondary 
antibody. Nuclei were stained with DAPI ®. Scale bars: 20um. 
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natal day (Gunaga et al. 1972, Leiderman & Mancini 1969). Additionally, other 
authors show that activity rates of glycogen synthase in testes are very low, 
while glycogen phosphorylase is much higher, concluding that glycogen 
amounts in testes of sexually mature animals are scarce. There are two 
important points to consider about this evidence: first, those studies used 
experimental techniques based on testicular polysaccharide staining, which is 
not specific for glycogen and the quantification is difficult; second, all of these 
studies were focused on the whole tissue without discriminating each cellular 
component of the testes. For these reasons and to functionally characterize 
the enzyme in these biological models, the activity rate of MGS was studied.  
Glycogen synthase activity was measured as mUnits of glycogen 
synthase per milligram of proteins [umol UDP-14C-glucose/min*mg protein] 
in the absence and presence of the allosteric activator glucose-6-phosphate 
[G6P]. The obtained activity values in the absence of G6P correspond to the 
enzyme that is intrinsically active. Meanwhile, the values acquired in the 
presence of the allosteric activator represent the total activity, which 
corresponds to the whole amount of the enzyme present in the cell extract. A 
very good approach to determine the proportion of the enzyme that is 
effectively active from the complete amount is the activity ratio -G6P/+G6P, 
where values below 0.1 indicate a fully inactive enzyme, and those above 0.7 
are equivalent to a complete activation (Guinovart et al. 1979). In primary 
Sertoli cell extracts, intrinsic glycogen synthase activity was 0.146±0.019 
mU/mg protein, while the total activity reached 5.101±0.446 mU/mg protein, 
and the activity ratio –G6P/+G6P was 0.0287±0.0043 [Figure 5, up]. Similar 
results where obtained in the Sertoli 42GPA9 cell line, where the activity rates 
in the absence of G6P was 0.176±0.023 mU/mg protein, in the presence of 
G6P 7.308±0.382 mU/mg protein and the activity ratio –G6P/+G6P,  
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Figure 5. MGS is almost inactive in Sertoli cells. Activity rates of primary 
Sertoli cell and Sertoli 42GPA9 cell extracts. Both were measured as mUnits 
of glycogen synthase per milligram of proteins [umol UDP-14C-
glucose/min*mg protein] in the absence [graphs in left, black bars] and 
presence [graphs in left, white bars] of the allosteric activator glucose-6-
phosphate [G6P]. The graphs on the right represent the ratio between –
G6P/+G6P activity rates, obtained for both Sertoli cell types and shown in 
the left graphs. Each graph indicates the mean and standard deviation of three 
independent experiments.  
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0.0237±0.0024 [Figure 5, down]. Intrinsic activity values in both Sertoli cell 
types were very low, indicating that MGS is almost inactive. Sertoli cell line 
42GPA9 showed higher values for total activity than the primary cells, 
corroborating the higher levels of the enzyme observed in the Figure 3. Total 
activity rates reached values 40 times higher in comparison with the intrinsic 
ones [Figure 5], demonstrating that MGS is effectively present but almost 
inactive in primary and 42GPA9 Sertoli cell extracts. For both Sertoli cell 
types, -G6P/+G6P activity ratios were no more than 0.03, confirming that 
only a very small part from the total MGS is active MGS and that almost all of 
the enzyme present is inactive. 
Another way to evaluate the MGS activity in Sertoli cells is analysing 
the phosphorylation state of the enzyme. Casein kinase II phosphorylates 
MGS Ser-656 [site 5, Figure 2], which is needed as a priming site for the 
GSK3 hierarchical phosphorylation of Ser-652, Ser-648, Ser-644 and Ser-640 
[sites 4, 3c, 3b and 3a, respectively, Figure 2] (Roach 1990, Skurat et al. 1994). 
This indicates that Ser-640 residue is the last site for GSK3 phosphorylation 
once casein kinase II begins to phosphorylate MGS. It has been reported, by 
Ser to Ala mutations, that sites 3b and 3a together with site 2 [Ser-7], were the 
most effective to promote the activation of MGS (Friedman & Larner 1963, 
Skurat et al. 1994). For this reason, the phosphorylation state of MGS in 
Sertoli cells was evaluated. 
Levels of total and phosphorylated MGS were compared previous and 
after phosphatase treatment. Total MGS was detected with the ct-MGS and 
the 3886 antibodies, while the phosphorylated enzyme was detected with the 
pS640MGS antibody, both in the presence and the absence of a wide range 
phosphatase in Sertoli cells [Figure 6]. Comparable results were obtained in 
primary and 42GPA9 Sertoli cells, corroborating the utilization of the cell line  
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Figure 6. Muscle glycogen synthase presents a highly phosphorylated 
state in Sertoli cells. Western blot analysis of primary Sertoli cell [up] and 
Sertoli 42GPA9 cell [down] extracts were treated [+] or not [-] with 200 units 
of λ Phosphatase, and then incubated with antibodies against total MGS 
[ctMGS] and its phosphorylated form in Serine 640 [pSer640MGS]. Graphs 
on right represent the quantification of band intensities as relative abundance 
for both MGS detections, taking as control the bands in the absence of λ 
Phosphatase and normalizing them with tubulin signal. Each graph indicates 
the mean and standard deviation of three independent experiments. 
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as a model for this study. Treatments with λ phosphatase successfully 
produced a decrease in the pS640MGS signals in comparison with non-treated 
cells [Figure 6]. This decrease in the phosphorylation signal for pS640MGS 
does not correspond to a difference in protein loading, because tubulin signals 
are similar in each line [Figure 6]. After quantifying the pS640MGS signals in 
treated and non-treated extracts, and normalizing them with tubulin, we 
determined that treatments produced a decrease in nearly half of the levels of 
pS640MGS [Figure 6]. On the other hand, after phosphatase treatments total 
MGS detection showed a band that runs faster in comparison with the total 
MGS band of non-treated extracts [Figure 6]. This reveals that MGS could be 
present in a highly phosphorylated state. Moreover, λ phosphatase treatments 
do not produce a decrease in the signals of total MGS as was observed for 
pS640MGS, proving that the enzyme is being dephosphorylated and not 
degraded [Figure 6]. Additionally, the use of antibodies against total MGS in 
the presence of λ phosphatase seemed to make the enzyme more 
immunoreactive in comparison to non-treated cells [Figure 6]. In turn, the 
intensification of the quantified total MGS signals after λ phosphatase 
treatments corresponds to a 50% increase of the observed signal in non-
treated Sertoli cell extracts [Figure 6]. These results suggest that MGS could 
be present in a high phosphorylation state, and that the antibodies against the 
total MGS are able to detect the enzyme more easily when it is 
dephosphorylated. The suggested high phosphorylation state for MGS 
reinforces the idea that this enzyme is almost inactive in Sertoli cells. 
Reported post-translational modifications of MGS are exclusively 
related to phosphorylation of different serine residues (Poulter et al. 1988). 
The enzyme has been described to be phosphorylated by several kinases on 9 
serine residues that are grouped into 4 phosphorylation clusters modulating 
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the MGS activity [see Figure 2 dotted lines], but always depending on G6P 
concentrations (Bouskila et al. 2010, Palm et al. 2013). The importance of 
these clusters is that single residue phosphorylation does not affect the MGS 
activity. While during a combinational or clustering phosphorylation, the 
enzyme activity decreases (Roach 1990, Skurat et al. 1994). These effects add 
relevance to the phosphorylation pattern of MGS, because its activity can be 
modulated by the combination of different phosphorylation sites, and this is 
directly associated to the activation of the different kinases. For these reasons, 
two dimensional gel electrophoresis was performed to elucidate the pattern of 
MGS post-translational modifications. 
Immunoprecipitated MGS, with the ct-MGS antibody, was obtained 
from muscle, brain, and Sertoli 42GPA9 cell extracts. The 
immunoprecipitated extracts were loaded and separated firstly by isoelectric 
focusing. Then, the separated proteins by their isoelectric point were run and 
separated by molecular weight in an SDS-PAGE gel and visualized by silver 
staining [Figure 7]. Muscle immunoprecipitated MGS was observed in a four 
spot pattern between pH 6,36-6,77 [Figure 7, upper gel]. In the case of brain 
immunoprecipitated MGS, 3 spots between pH 6,30-6,67 were observed, and 
another set localized more in the middle of the gel approximately to pH 5.8 
[Figure 7, middle gel]. Meanwhile, Sertoli immunoprecipitated MGS was 
spotted in two different forms: one more basic localized in pH 7; and another 
set of eight spots more acidic ranging to the pH 5.55-6.35 [Figure 7 bottom 
gel]. 
MGS separation by 2D gel electrophoresis of muscle and brain MGS 
showed a similar pattern in the more basic MGS forms [pH 6,3-6,7]. 
However, only the brain and not the muscle MGS was spotted in the more 
acidic pH [5,8]. In contrast, Sertoli MGS presented a clearly different pattern  
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Figure 7. Sertoli muscle glycogen synthase presents a different two-
dimensional gel electrophoresis pattern in comparison with muscle and 
brain. Five hundred micrograms of muscular, brain and Sertoli cell extracts 
were used to immunoprecipitate the MGS. Each pulled down extract was 
precipitated overnight with acetone and then solubilized with solubilisation 
buffer supplemented with 8M urea, 20 mM DTT and 0.5% IPG buffer. 
Samples were separated firstly by isoelectric focusing between pH 4-7, and 
subsequently by molecular weight in a 10% SDS-PAGE. Finally, 
immunoprecipitated proteins were visualized by silver stain. Black squares 
indicate the different patterns of MGS forms in each gel. 
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when compared with the muscle and brain forms. The basic spot in pH 7 was 
not present in muscle nor in the brain. Also the more acidic eight spot pattern 
between the pH 5,55-6,35 was not observed for the muscle form, but could 
be similar to the more positive spots visualized for the brain MGS form. 
Thus, these results showed that Sertoli cells present a different form of the 
enzyme in comparison with muscle and brain. Also an important point to 
highlight is the presence of two populations of the enzyme. The MGS spots 
localized to more acidic pH of the 2D gel electrophoresis agrees with the 
activity and phosphatase assays, because they can also be associated with the 
high levels of MGS phosphorylation and inactivity. 
Overexpression of PTG [Protein Targeting to Glycogen] is a valuable 
approach to induce glycogen synthase activity. This scaffold protein is 
responsible to drive the Protein Phosphatase 1 [PP1] to glycogen, where 
glycogen synthase is situated. Once situated in glycogen, PP1 is able to 
dephosphorylate and activate the enzyme stimulating the accumulation of 
glycogen. This experimental methodology was used in this work to evaluate 
how susceptible is MGS to dephosphorylation when PTG is overexpressed. 
Since this should activate the total amount of the expressed enzyme even in 
the absence of the allosteric activator G6P.  
PTG overexpression was achieved through the infection with 
adenoviral particles that encode GFP, as a control, and GFP-PTG in both 
Sertoli cell models. After 48 hours of infection, Sertoli cells expressed both 
GFP and GFP-PTG, so all the adenoviral infection related experiments were 
made in this time lapse [data not shown]. In the absence of the allosteric 
activator G6P very low activity rates of MGS were described, 0.146±0.019 
mU/mg protein and 0.176±0.013 f mU/mg protein for primary and 42GPA9 
Sertoli cells, respectively [Figure 5 and 8A]. However, when PTG is  
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Figure 8. Muscle glycogen synthase is susceptible to activation by 
Protein Targeting [PTG] overexpression in Sertoli cells. Primary Sertoli 
cells and Sertoli 42GPA9 cells were transduced with adenoviral particles to 
overexpress GFP [Ad GFP], as an infection control, and PTG-GFP [Ad 
PTG] to activate the enzyme. The overexpression of GFP and PTG-GFP was 
corroborated by fluorescent microscopy. Maximal fluorescent signals were 
detected after 48 hours post infection for both, AdGFP and AdPTG. The 
MGS activity rates of primary Sertoli cells [black bars], Sertoli 42GPA9 cells 
[white bars] and PTG-transduced Sertoli 42GPA9 cells [grey bars] in the 
absence, A), and presence, B), of the allosteric activator glucose-6-phosphate 
[G6P] are shown. C) These values were used to determine the ratio between 
the activity rates –G6P/+G6P. Each graph indicates the mean and standard 
deviation of three independent experiments. D) Glycogen content 
measurement of non-infected, AdGFP transduced [GFP] and AdPTG-GFP 
transduced primary Sertoli cells [black bars] and Sertoli 42GPA9 cells [white 
bars]. The values are shown as fold change over the AdGFP transduced 
Sertoli cells of a single experiment. 
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overexpressed, the enzyme activity increased approximately 15 times, reaching 
2.331±0.178 mU/mg protein [Figure 8A, grey bar]. This means that PTG 
overexpression effectively induced the activation of MGS in Sertoli cells. 
Nevertheless, the activation magnitude is not total nor affects the whole 
amount of the expressed enzyme because it does not reach total activity 
values. This was demonstrated in the same activity assays but in the presence 
of the allosteric activator, where similar levels of activation were observed in 
non infected [7.308±0.382 mU/mg protein], and in PTG infected 42GPA9 
cells [7.231±0.512 mU/mg protein] [Figure 8B, white and gray bars], proving 
that higher glycogen synthase activity rates during PTG overexpression were 
not due to an increase in MGS expression. Similarly, activity ratio –
G6P/+G6P analyses indicated that in Sertoli cells that overexpress PTG this 
ratio rises to 0.323±0.0136, from the observed 0.0287±0.0043 and 
0.0237±0.0024 in non-infected primary and 42GPA9 Sertoli cells, respectively 
[Figure 8C].  
All the obtained activity data reveals that PTG overexpression was 
unable to induce a complete activation of MGS, because in the absence of 
external G6P, the activity values increased only to one third with respect to 
what was observed in the presence of the allosteric activator. Also, this is 
reinforced by the activity ratio –G6P/+G6P value in PTG infected cells 
[≈0.323], which did not reveal total activation of the enzyme that is described 
to be 0.7 or more (Guinovart et al. 1979). 
To validate the activation of the enzyme, glycogen content measuring 
was performed in AdPTG infected Sertoli cells using AdGFP infection as a 
control [Figure 8D]. Glycogen amounts of non-infected primary and 42GPA9 
Sertoli cells were very similar in comparison with the control of infection 
[GFP, Figure 8D]. Meanwhile in AdPTG infected cells, glycogen content 
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increased ≈30 times and ≈150 times, in primary and 42GPA9 Sertoli cells, 
respectively [Figure 8D]. This reveals that despite the partial activation of 
MGS in AdPTG infected Sertoli cells, the fraction of activated enzyme is 
capable of synthesizing larger amounts of glycogen. No statistical analysis was 
made because the large differences of the obtained values for intrinsic activity 
and glycogen content between control [AdGFP] and AdPTG infected cells. 
Another experimental methodology described to activate glycogen 
synthesis is the treatment with lithium salts. Lithium indirectly activates 
glycogen synthesis through the inhibition of Glycogen Synthase Kinase 3 
[GSK3], which is constitutively active and phosphorylates key residues that 
regulate glycogen synthase activity [Ser640]. This ion acts as an inhibitor of 
mammalian GSK3 by competing for Magnesium [Mg2+], but not for the 
substrate or ATP sites (Ryves & Harwood 2001). In 3T3-L1 adipocytes and 
L6 myotubes, lithium chloride treatments induce glucose incorporation and 
glycogen synthesis, exhibiting an insulin-like behaviour, without preventing 
the desensitization of glycogen synthase activity after chronic insulin 
treatments (MacAulay et al. 2003, Oreña et al. 2000). In these reports, lithium 
treatments were performed using millimolar concentrations [50 mM]. 
Therefore, to study the activation of MGS by lithium treatments, 90mM LiCl 
was used considering the low levels of intrinsic activity and higher level of 
phosphorylation in both Sertoli cell types. 
In the absence of G6P, intrinsic activity of MGS in 42GPA9 Sertoli 
cells [0.176±0.023 mU/mg protein] was slightly increased during lithium 
chloride treatments [0.246±0.019 mU/mg protein] [Figure 9A]. By contrast, 
in the presence of G6P total activity of the enzyme suffered a decrease from 
7.308±0.382 mU/mg protein to 4.460±0.395 mU/mg protein after lithium 
chloride was added [Figure 8A]. This suggests that lithium treatments cause a  
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Figure 9. Muscle glycogen synthase is weakly activated by lithium 
treatment in Sertoli cells. A) MGS activity rates in the absence [-G6P] and 
presence [+G6P] of the allosteric activator glucose-6-phosphate, in non-
treated [CTL, black bars] and 90 mM lithium chloride treated [Li, grey bars] 
Sertoli 42GPA9 cells. B) The values in A) were used to calculate the ratio –
G6P/+G6P of the activity rates, in non-treated [CTL, black bars] and 90 mM 
lithium chloride treated [Li, grey bars] Sertoli 42GPA9 cells. Each graph 
indicates the mean and standard deviation of three independent experiments. 
C) Glycogen content quantification in non-treated [CTL] and 90mM lithium 
chloride treated primary Sertoli cells [black bars] and Sertoli 42GPA9 cells 
[white bars]. Values of  single experiment are expressed as the fold change 
over the non-treated cells. 
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decline in the expression of MGS in Sertoli cells. Then, by analysing the 
activity ratio –G6P/+G6P, lithium treated cells showed a 2-fold increase 
compared to non-treated cells [0.0241±0.0018 to 0.0552±0.001] [Figure 9B]. 
This increase is still not sufficient to activate the enzyme, and this was 
corroborated by glycogen accumulation measurements. For both Sertoli cell 
types, lithium produced a small increment in glycogen content comparable to 
the one observed in non-treated control. The rise in the glycogen content was 
approximately 2.1 and 3 times in primary and 42GPA9 Sertoli cells, 
respectively [Figure 9C]. Thus, these results revealed that lithium treatments 
caused a decrease in the total activity of MGS, which in turn, affects the total 
levels of functional MGS in Sertoli cells. Additionally, the small portion of 
MGS that is activated was capable only of duplicating and triplicating the 
glycogen content for primary and 42GPA9 Sertoli cells, respectively. 
In muscular, fibroblast, and hepatic cells, GFP-MGS fusion protein was 
described to translocate from the nucleus to the cortex of the cells, near the 
membrane, where glycogen synthesis starts in response to glucose treatments 
(Cid et al. 2005, Fernández-Novell et al. 1997, Ferrer et al. 1997). This 
behaviour denotes that MGS is an enzyme that can change its subcellular 
localization in response to external stimulus. 
For this reason and for the observed effects of lithium in the enzyme 
activity, MGS localization analyses during lithium treatments of Sertoli cells 
were carried out. By confocal immunofluorescence of Sertoli 42GPA9 cells, 
total MGS and pS640MGS localization was analysed in non-treated [control] 
cells versus lithium chloride treated cells [30mM and 90mM]. In control cells, 
total MGS was homogenously distributed in a dotted pattern over the 
cytoplasm [Figure 10A, up and left]. During lithium treatments with 30 and 90 
millimolar, MGS was accumulated in cytoplasmic granules that were no more  
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Figure 10. Lihtium treatments induce the formation of cytosolic 
granules of glycogen synthase in Sertoli cells. A) and B), confocal 
immunofluorescent images of fixed and permeabilized cells that were 
incubated with antibodies against total MGS [MGS] and its phosphorylated 
form in Serine 640 [pS640MGS] in a dilution of 1:200. The secondary 
antibody Alexa-488 donkey anti rabbit IgG was used in a dilution of 1:300. 
Nuclei were stained with propidium iodide [PI]. Scale bars 20 um. In A), non-
treated [Control], 30mM lithium chloride treated [30mM Li+] and 90mM 
lithium chloride treated [90mM Li+] Sertoli 42GPA9 cells were used to detect 
total MGS [up] and pS640MGS [down]. In B), primary Sertoli cells of mice 
treated with 6 umol Li2CO3 per day during 30 days were assessed. These 
primary cultures were mantained for two [left] and 8 days [rigth] before the 
fixation. Then total MGS [left] and pS640MGS [rigth] were detected. Phase 
contrast is shown to visualize the shape and vacuolization of the cells. [both 
images up]. C) Transmission electronic microscopy analysis of 90mM lithium 
chloride treated Sertoli 42GPA9 cells. Scale bar, 250 nm. A zoom-in of the 
interested region of Sertoli cell cytoplasm is shown in the lower image. Scale 
bar, 50 nm. 
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than two or three per cell [Figure 10A, up center and right]. The pS640MGS 
was found dispersed in the cytoplasm with a nuclear-speckled pattern [Figure 
10A, down and left]. Corresponding to what was observed with the total 
MGS immunolocalization, a cytoplasmic granule accumulation of the 
phosphorylated enzyme was visualized during lithium treatments [Figure 10A, 
down center and right]. Any MGS granule was observed by treating Sertoli 
cells with NaCl, proving that lithium was the responsible for the MGS granule 
formation and to discard the influence of the hyperosmotic effect [data not 
shown]. 
Lithium effects on testicular cells have been reported to be ambiguous. 
Some of them refer to lithium as a toxic agent for testicular cells, thus causing 
deleterious effects on the seminiferous epithelium. By contrast, others have 
shown that this ion has positive effects by protecting testes from the damage 
caused by cadmium (Al-Azemi et al. 2010, Banerji et al. 2001, Thakur et al. 
2003, Zarnescu & Zamfirescu 2006). All these studies have focused their 
experimental procedures on histological and ultra-structural analysis of the 
seminiferous tubule, without investigating the molecular events where lithium 
takes place. In the present work, we decided to corroborate in vivo the 
observed effects in the cell line 42GPA9 regarding MGS re-localization 
[Figure 10A]. To prove this, mice were treated with therapeutic doses of 6 
umoles per day of lithium carbonate [Li2CO3] for 30 days. Then, primary cell 
cultures of Sertoli cells from treated mice were maintained for two and eight 
days post-primary culture. After this time interval, cells were fixed and assayed 
by confocal immunofluorescence, confirming the cytosolic accumulation in a 
granule like structure of the MGS at both days [Figure 10B, down]. 
Additionally, primary Sertoli cells presented numerous vacuoles in the 
cytoplasm, which is an evident sign of stress [Figure 10B, up]. 
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To elucidate the ultra-structural characteristics of these cytoplasmic 
granules, the samples were assessed by transmission electron microscopy 
[TEM]. Sertoli 42GPA9 cells were treated with 90mM LiCl for 24 hours 
before fixation, and TEM analysis showed the formation of an electrodense 
structure in the cytoplasm [Figure 10B, zoom out]. Interestingly, this 
electrodense structure viewed in a higher zoom has a glycogen like shape 
[Figure 10C, zoom in]. When compared with non-treated cells it is important 
to highlight that none of these structures or something similar was observed, 
indicating that lithium was responsible for the formation of these granules and 
those could be related to the observed small increase of glycogen content in 
Figure 9C. 
These results show the effect of lithium on the Sertoli 42GPA9 cell line 
and reinforce the idea that this ion barely induces MGS activity. However, the 
small activation is able to provoke the re-localization of the enzyme in the 
cytosol, possibly to glycogen particles, which apparently causes stress to 
Sertoli cells. 
 
4.2 Muscle Glycogen Synthase and RNA binding proteins 
Several metabolic enzymes have been reported to bind RNA molecules, 
and moreover, to regulate the expression of different mRNAs, including their 
own (Castello et al. 2012b, Cieśla 2006). In the case of MGS, it has been 
related directly and indirectly to RNA binding proteins, ribonuclear particles, 
and thus RNA molecules. MGS interacts with many proteins including laforin 
and malin, which regulate its degradation through the ubiquitin proteasome 
system, and both of them are functionally expressed in Sertoli cells (Vilchez et 
al. 2007, Villarroel-Espíndola et al. 2013). Both proteins have been connected 
to RNA metabolism, providing indirect associations of MGS and RNAs. In 
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HeLa cells, Laforin, a dual phosphatase of tyrosine and serine/threonine 
residues, was found in the cytoplasm associated with polyribosomes (Ganesh 
et al. 2000), while Malin, an E3 ubiquitin ligase, was discovered to be recruited 
to processing bodies co-localizing with different markers like AGO2, Dcp1, 
Xrn1, and GW182 (Singh et al. 2012). In the case of MGS, it has been directly 
related to ribonuclear particles. The enzyme, and specifically pS640MGS, was 
found to be associated to translationally active polyribosomes, not with the 
inactive ones, suggesting a role in the modulation of ribosome activity in 
HeLa cells (Fuchs et al. 2011). These reports, in addition to the presence of an 
almost inactive enzyme, led us to propose the existence of some association 
between MGS and RNA and RNA binding proteins in Sertoli cells. 
RNA interference [RNAi] works as a gene silencing pathway and has 
been described in Sertoli cells as a vital process for spermatogenesis 
(Papaioannou et al. 2009). This process is achieved by many conserved 
elements, including RNAseIII enzymes and components of the RNA-induced 
silencing complex [RISC]. One of the main components of the RISC complex 
is the protein Argonaute2 [AGO2], because it is responsible for the cleavage 
activity of RISC (Liu et al. 2004, Meister et al. 2004). AGO2 belongs to a 
family of proteins that interact with small interfering RNAs [siRNAs], micro 
RNAs [miRNAs] and Piwi RNAs [piRNAs] regulating gene expression at the 
level of transcription, mRNA stability and translation (Rüdel et al. 2008, 
Younger & Corey 2011). Interestingly, elevated expression levels of this 
endonuclease have been reported in testes and specifically in the somatic 
Sertoli cells when compared with germ cells (González-González et al. 2008). 
For these reasons, and keeping in mind the indirect associations of MGS with 
RNAi, the idea that MGS could interact with some RNA binding proteins like 
AGO2 was developed. The interaction was assessed by performing co-
! 69!
immunofluorescence and co-inmunoprecipitation assays using specific 
antibodies against the enzyme and Argonaute-2 [AGO2]. 
Confocal co-immunofluorescence analysis in primary Sertoli cells 
showed the aforementioned localization of total MGS homogenously over the 
cytoplasm [Figure 11, left MGS in green]. Similarly, AGO2 
immunolocalization was also distributed in the cytoplasm in a dotted pattern, 
including the nucleus [Figure 11, left AGO2]. Co-localization of both MGS 
and AGO2 immunodetections was evident in numerous regions of the 
cytoplasm and also in the perinuclear area, creating a ring like pattern [Figure 
11, left MERGE]. It is important to emphasize that despite high levels of 
MGS and AGO2 co-localization not all the fluorescent signals co-localize 
between them, as observed in some peripheral zones of the Sertoli cell 
cytoplasm [Figure, 11, left MERGE]. 
RNAi-mediated gene silencing by AGO2 requires the presence of 
several components that are described to be present in different ribonuclear 
particles [RNPs] like processing bodies, stress granules and chromatoid bodies 
among others (Moser & Fritzler 2010). From a single cell, the spatiotemporal 
localization of these components varies from being present in all the RNPs, 
like AGO2, to being part of some percentage of some RNPs, a fact that 
demonstrates the dynamism of proteins and RNAs that interchange between 
different RNPs (Moser & Fritzler 2010). These components include proteins 
involved in mRNA degradation, stabilization, processing and transport where 
Dicer, AGO2, GW182, CCR4, XRN1, DDX6, Staufen and CPEB among 
others, have been described (Eulalio et al. 2007). 
In Sertoli 42GPA9 cells, co-immunofluorescence analyses between 
MGS, AGO2 and CPEB1 showed that each immunofluorescent signal is 
localized throughout the cytoplasm [Figure 11, right]. For the case of CPEB1,  
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Figure 11. MGS co-localize with two RNA binding proteins, AGO2 and 
CPEB1, in Sertoli cells. Co-immunofluorescence studies of fixed and 
permeabilized primary Sertoli cells [left] and Sertoli 42GPA9 cells [right]. 
Primary Sertoli cells were incubated with antibodies against total MGS [green] 
and AGO2 [red] in a dilution of 1:200, and then with the secondary antibodies 
Alexa-488 donkey anti rabbit IgG and Alexa-568 donkey anti mouse IgG in a 
dilution of 1:300. Co-localization of the immunofluorescent signals in yellow 
are shown in MERGE. Nuclei were stained with DAPI®. Sertoli 42GPA9 
cells were treated as primary Sertoli cells, but adding an antibody against 
CPEB1, without staining the nuclei, and revealing the immunodetection with 
the secondary antibodies: Alexa-488 donkey anti mouse IgG, Alexa-568 
donkey anti goat IgG and Alexa-633 donkey anti rabbit IgG. The co-
localization of the immunofluorescent signals are shown in MERGE, where 
triple co-localization is signed with a large arrow, and double co-localization 
between MGS and AGO2 is indicated with small white arrows. Scale bars, 20 
um. 
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it is particularly accumulated in certain zones of the cytoplasm, in a well 
defined pattern near the nucleus [Figure 11, right CPEB1 in blue]. Moreover, 
MGS and AGO2 presented a homogenous distribution of their 
immunofluorescent signals in the whole cytoplasm, in a bigger dotted pattern 
with respect to the primary cells, and AGO2 was barely detected in the 
nucleus [Figure 11, right MGS in green and AGO2 in red]. MGS and AGO2 
co-localization was observed in specific points of the cytoplasm and also in 
some perinuclear zones [Figure 11, right, MERGE small arrows]. The co-
localization analysis of the three signals revealed that MGS, AGO2 and 
CPEB1 co-localize in specific areas of the cytoplasm, but principally in a zone 
near the nucleus where CPEB1 is mainly located [Figure 11, right, MERGE 
big arrow]. 
To further validate the possible interaction of MGS and AGO2 
observed by immunofluorescence co-localization, co-inmunoprecipitation of 
both proteins was carried out. In order to perform these assays, it was firstly 
analysed the best conditions and which antibodies worked better to 
immunoprecipitate the enzyme. Until now there are no reports about the 
detection of MGS in testes, only glycogen measurements. Therefore, there is 
no information about the specificity of the antibodies to detect the enzyme in 
Sertoli cells. To accomplish that, MGS was immunoprecipitated using the 
three antibodies used in this work [Figure 12]. The first against the C-terminal 
region of the MGS [ctMGS] that should detect total, phosphorylated and 
unphosphorylated, forms of the enzyme, another, that was described to 
distinguish also both enzyme states [3886], and a third antibody specifically 
against the phospho-Ser640 [pS640MGS]. 
MGS immunoprecipitation was assayed with Sertoli 42GPA9 cell 
extracts, where a strong band was observed for the case of the ctMGS - 
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Figure 12. The antibody against the carboxy terminal region is the most 
effective to immunoprecipitate muscle glycogen synthase in Sertoli 
cells. Formaldehyde crosslinked Sertoli 42GPA9 cell extracts were used to 
immunoprecipitate MGS by using three different antibodies. Total MGS was 
immunoprecipitated with the ctMGS and 3886 antibodies, while the 
phosphorylated form of the enzyme in serine640 was pulled down with the 
pSMGS antibody. Each immunoprecipitated extract was loaded and separated 
in an SDS polyacrylamide gel electrophoresis and stained with Coomassie 
blue. The bands that correspond to MGS by size [≈85 KDa] were excised 
from the gel [red squares] and analysed by mass spectrometry. The proteins 
identified in all three immunoprecipitations are listed below the gel. The size 
of the name reflects the abundance of the proteins in the pulled down 
extracts. At the right of the list the number of MGS peptides identified for 
each antibody are summarized. Muscle glycogen synthase [Gys1], Heat shock 
protein 90-beta [HSP90-b], Polyubiquitin-B [PoliUb-B], Heat shock protein 
90-alpha [HSP90-a], DNA replication licensing factor MCM5 [MCM5], 
Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 
[DHX15] 
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immunoprecipitation in comparison with the other two antibodies [Figure 12, 
red squares]. Then, the selected bands by size [≈80-90 KDa] were excised and 
digested with trypsin to analyse them by nanoscaled liquid chromatography 
coupled to tandem mass spectrometry [nano LC-MS/MS]. The nano LC-
MS/MS analysis revealed that the antibodies effectively identified MGS in 
Sertoli cells [GYS1], with a size that has been described for this enzyme, 85 
KDa. Additionally to MGS, other proteins were co-immunoprecipitated, 
where cytosolic [heat shock protein 90, HSP90, and polyubiquitin-B, PoliUb-
B] and nuclear proteins [DNA replication licensing factor MCM5, and 
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15] 
were found [Figure 12]. Additionally, this study revealed a clear difference 
between ctMGS, 3886 and pS64MGS antibodies, showing that the best one to 
immunoprecipitate the enzyme was ctMGS. The immunoprecipitation [IP] 
with this antibody detected 28 unique peptides of the enzyme, while the 3886 
and pS640MGS antibodies only detected two and three peptides, respectively 
[Figure 12]. Thus, the antibody against the C-terminal region was used to co-
immunoprecipitate MGS and AGO2 to validate the co-localization assays. 
Sertoli 42GPA9 cell extracts were used to detect AGO2 by Western 
blot after the immunoprecipitation of the MGS and vice versa, using a rabbit 
IgG [Rb IgG] as a control of co-IP [Figure 13]. The AGO2 immunoreactive 
signal was described to be near 90 KDa, but this band was not evidenced after 
the immunoprecipitation of ctMGS as in the control [Figure 13A, up]. 
Despite this, and as was predicted by mass spectrometry analysis, an effective 
IP of the MGS with the ctMGS antibody was observed [Figure 13A, down]. 
This was visualized as a strong band for the MGS in the ctMGS IP lane, when 
compared with the control, and a decrease in the signal for the unbound [UB]  
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Figure 13. pS640MGS co-immunoprecipitates with AGO2 in Sertoli 
cells. Co-inmunoprecipitation analyses were carried out in Sertoli 42GPA9 
extracts. A) Western blot detection of AGO2 [up] after the 
immunoprecipitation of the MGS with the antibody against the carboxy 
terminal region of the enzyme. The pull down of MGS was corroborated by 
the detection of ctMGS [down]. B) Western blot detection of pS640MGS 
[up] after the immunoprecipitation of AGO2. The pull down of AGO2 was 
corroborated by it own detection [down]. For both co-inmunoprecipitation 
assays a rabbit IgG was used as negative control. Lanes labelled unbound 
[UB] correspond to the fraction of the extracts that did not 
immunoprecipitate, while IP corresponds to the immunoprecipitated fraction. 
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when compared with the INPUT, although the same protein amount was 
loaded [Figure 13A, down]. 
On the other hand, when AGO2 was immunoprecipitated, the 
phosphorylated form of the enzyme [pS640MGS] was detected, 
demonstrating the co-inmunoprecipitation. This was done because previous 
results showed that phosphorylated MGS was the main form of the enzyme 
present in Sertoli cells, making it more detectable by Western blot. This 
phenomenon was observed in the PPase experiments where total MGS 
detection was more efficient only in cases when the enzyme was 
dephosphorylated in both Sertoli cell models [Figure 6]. Thus, when 
pS640MGS was evaluated by Western blot in AGO2 IP extracts, a positive 
band appeared for the phosphorylated enzyme in the AGO2 IP lane and not 
in the negative control of the IP [Figure 13B, up]. Next, to corroborate 
AGO2 IP, the same protein was blotted, indicating that AGO2 was effectively 
immunoprecipitated, while no signal was observed in the control [Figure 13B, 
down]. In summary, these results showed that part of the phosphorylated 
form of the enzyme [pS640MGS] is interacting with AGO2, and this cannot 
be observed when the total enzyme [ctMGS IP] is immunoprecipitated. Also, 
these co-IP experiments revealed a different performance of the MGS 
antibodies, where the ctMGS antibody works better for MGS IP, while the 
pS640MGS works better for Western blot detection. 
To strengthen the proposal that MGS could interact with different 
RBPs, and given that these proteins are always interacting in the RNPs, the 
interaction of MGS with other RBPs was examined [Figure 14]. Those RBPs, 
include AGO2, and the cytoplasmic polyadenylation element-binding 
proteins, CPEB1 and 4, together with the ATP-dependent RNA helicase, 
DDX6. In primary Sertoli and Sertoli 42GPA9 cell extracts, the pS640MGS  
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Figure 14. pS640MGS co-immunoprecipitates with different RNA 
binding proteins in Sertoli cells. Co-inmunoprecipitation assays were 
performed in primary Sertoli cell [up] and Sertoli 42GPA9 cell [down] 
extracts. For both cases, pS640MGS was detected by Western blot after the 
inmunoprecipitation of AGO2, CPEB1, CPEB4 and DDX6. In the UB lanes 
were loaded the unbound extracts that do not immunoprecipitate, while the 
immunoprecipitated are shown in the IP lanes. Unbound [UB], 
immunoprecipitated [IP]. 
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was detected after the IP of AGO2, CPEB4, CPEB1 and DDX6. The same 
band with different intensities was observed in the IP lanes for the 
phosphorylated form of the enzyme in both Sertoli cell types [Figure 14]. In 
primary Sertoli cells, pSMGS640 immunoreactive signal was more intense for 
AGO2 and CPEB1 IPs, in comparison with CPEB4 and DDX6 IPs [Figure 
14, up]. Whereas in Sertoli 42GPA9 cells, the most intense bands for 
pS640MGS were observed in AGO2 and CPEB4 IPs, rather than in DDX6 
and CPEB1 IPs. [Figure 14, down]. Consequently, pS640MGS coIPs with 
different RBPs including AGO2 in both Sertoli cell types supporting the idea 
that MGS could interact with some RNPs components in Sertoli cells. 
Remarkably, despite different signals observed in all the IPs for both 
Sertoli cell types, higher intensities for pS640MGS were always detected 
during AGO2 IPs. For this reason, and given the relevance of AGO2 for the 
RNAi process in concordance with the high levels of this endonuclease 
founded specifically in Sertoli cells, the pS640MGS-AGO2 interaction was 
studied. At this point it is unknown if this interaction is direct, or if it depends 
on other components or the state of those components. To test some of the 
possible features of the pS640MGS-AGO2 interaction, the coIPs were 
performed in the presence of an RNAse or changing the activity and 
phosphorylation state of the MGS [Figure 15].  
To analyse if the interaction depends on an RNA molecule, primary 
and 42GPA9 Sertoli cells extracts were treated [or not] with RNAse A, prior 
to AGO2 immunoprecipitation. In both cell types, pS640MGS was detected 
to similar extend in AGO2 IP from RNAse treated or non-treated extracts 
[Figure 15A and C]. Although a more intense band for pS640MGS was 
observed in the absence of RNAse treatment in primary Sertoli cells [Figure  
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Figure 15. Co-immunoprecipitation of pS640MS with AGO2 does not 
require the presence of RNA molecules and is not affected by PTG 
overexpression. Western blot analysis for pS640MGS after the 
inmunoprecipitation of AGO2 in primary Sertoli cell [left] and Sertoli 
42GPA9 cell [rigt] extracts. A) and C), before the immunoprecipitation, both 
Sertoli cell extracts were treated [+] or not [-] with RNAse A. In B) and D), 
both Sertoli cell types were transduced with AdGFP alone and AdPTG-GFP, 
as described in Figure 7. For all the cases, in the UB lanes were loaded the 
unbound extracts that do not immunoprecipitate, while the 
immunoprecipitated are shown in the IP lanes. Unbound [UB], 
immunoprecipitated [IP]. 
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15A]. While in Sertoli 42GPA9 cell extracts, equivalent intensity signals for 
pS640MGS were detected in treated and non-treated extracts [Figure 15C]. 
On the other hand, to study if the activity state of the enzyme is crucial 
for the interaction of pS640MGS and AGO2, the inactive state of the enzyme 
was partially reverted. To accomplish that, both Sertoli cell types were 
infected with adenoviral particles that encode for GFP-PTG, and GFP alone 
as a control, to activate the MGS as was described in the Figure 8. In both 
Sertoli cell types pS640MGS detection after the IP of AGO2 was undoubtedly 
positive in AdGFP infected cells, whereas in AdPTG infected cells, 
pS640MGS detection in the input and unbound [UB], was substantially 
reduced [Figure 15B and D]. Despite this, ctMGS detection revealed the 
presence of the enzyme in the input and UB lanes [Figure 15B and D, WB 
ctMGS]. The reduction in the pS640MGS signal in AdPTG infected cells was 
most probably due to the overexpression of PTG, which promotes MGS 
activation by its dephosphorylation. Interestingly, however one portion of the 
remaining phosphorylated enzyme in Ser640 was still co-immunoprecipitating 
with AGO2 in both Sertoli cell types [Figure 15B and D]. These results 
indicate two features of the [direct/indirect] interaction of pS640MGS and 
AGO2. First, that this interaction was not dependent on the presence of RNA 
molecules. Second, that despite the enzyme activation by dephosphorylation, 
a fraction of the phosphorylated enzyme still immunoprecipitates with 
AGO2. 
After observing that pS640MGS interacts with RNPs components and 
specifically with AGO2, it was reasoned that if the enzyme was interacting 
with RBPs it should also associate directly or indirectly with RNA molecules. 
To test this idea, RNA purification after the immunoprecipitation of the  
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Figure 16. Schematic illustration of the RNA inmunoprecipitation 
[RIP] protocol. Sertoli cells in approximately 80% confluence were 
crosslinked with 1% formaldehyde for 15 minutes. Then, they were washed 
and lysed mechanically by soft sonication and syringe passages. The obtained 
protein extract and the glycogen synthase antibodies coupled to Dynabeads ® 
Protein A, were incubated together during 4 hours to immunoprecipitate the 
enzyme. Next, one third of the immunoprecipitated extracts was used to 
confirm the immunoprecipitation by Western blot analysis. The other two 
thirds were heated to revert the crosslinking, and then treated with proteinase 
K to eliminate proteins. Afterwards, RNA molecules were purified, and 
treated with DNAse, for a subsequent analysis by a microarray of the 
immunoprecipitated RNAs with the glycogen synthase. 
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enzyme was performed. An RNA inmunoprecipitation [RIP] assay is 
described below and schematized in Figure 16. 
Several studies have used this experimental procedure to determine, for 
example, the proteins associated with miRNA-regulated mRNAs and 
associated mRNAs to a pivotal protein that mediates translational control 
during cancer progression in adenocarcinomas and glioblastomas (Ortiz-
Zapater et al. 2012, Shih et al. 2011). The RNA immunoprecipitation is based 
in a formaldehyde-induced crosslinking between any primary amino group. 
Formaldehyde crosslinking occurs between nearby nitrogen atoms in another 
protein, DNA, or in this case RNA through a -CH2- linkage. The most 
relevant consequence of formaldehyde treatment during RIP is that the 
association between proteins and RNAs molecules are captured as an in vivo 
snapshot inside a cell. After the crosslinking, the cells were lysed and protein 
extracts were used to immunoprecipitate a protein of interest, in this case the 
glycogen synthase. Accordingly, the immunoprecipitated extracts were split in 
two, where one third was used to verify the immunoprecipitation by Western 
blot and the other two thirds were used to purify RNAs. Prior to RNA 
purification, the protein components of the IP extracts were digested with 
Proteinase K and the crosslinking was reverted with temperature as described 
in 3.2.6.4. Next, the purified RNAs were treated with DNAse to degrade any 
remaining contaminant DNA to finally analyse the immunoprecipitated RNAs 
by a microarray profiling. 
For MGS it was already determined that the ctMGS is the best 
antibody to immunoprecipitate the enzyme by mass spectrometry, as was 
shown in Figure 12. Thus, crosslinked primary Sertoli cell extracts were used 
for RNA immunoprecipitation assays with the ctMGS antibody, and also, 
with a rabbit IgG [Rb IgG] as a negative control for the IP. Additionally, the  
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Figure 17. MGS pull down confirmation previous to the RNA 
purification during RIP. MGS immunoprecipitation was confirmed by 
Western blot analysis using primary Sertoli cell extracts. ctMGS and 
pS640MGS antibodies were used to pull down the enzyme and a rabbit IgG 
[RB IgG] was used as the negative control. The immunoprecipitation was 
firstly detected with the ctMGS antibody during short [1 minute] and long [5 
minutes] exposure times [up]. Then, the membrane was “stripped” and re-
probed against the pS640MGS and also exposed during short [1 minute] and 
long times [5 minutes]. In the UB lanes the unbound extracts that do not 
immunoprecipitate were loaded, while the immunoprecipitated fractions are 
shown in the IP lanes. 
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same experiment with the pS640MGS antibody was performed to analyse the 
reproducibility of the RIP with different antibodies [Figure 17]. Once the 
crosslinking and the immunoprecipitation were made, one third of each IP 
was analysed by Western blot to detect the MGS with the ctMGS antibody. 
The blot showed an effective inmunoprecipitation of the enzyme with 
the ctMGS antibody [Figure 17, up, IP ctMGS lane]. Surprisingly the 
enzymewas not detected in the Input, UB and pS640MGS IP lanes after a 
short exposure time of the membrane, and this barely changed after a longer 
exposure, where faint signals for ctMGS appear [Figure 17, up]. This evidently 
attracted our attention because of the weak detection of the enzyme, so the 
membrane was “stripped” and re-blotted, but now against the pS640MGS. 
Interestingly, the “stripped” membrane showed that pS640MGS was now 
easily detectable in the Input and UB lanes, and also in the ctMGS IP lane at 
short exposure times [Figure 17, down, short exposure]. However, under 
these conditions no IP of the pS640MGS was detectable, so the exposure 
time was extended and a very weak band for the phosphorylated enzyme was 
observed in pS640MGS IP lane [Figure 17, down, long exposure]. It is 
important to highlight that no bands for the ctMGS, nor for the pS640MGS, 
were observed in the Rb IgG IP lanes, demonstrating that the negative 
control was successful under our IP conditions. This was very important for 
this work because this negative control for the IPs [Rb IgG Ip] was the 
negative control for the microarray data. These results are in agreement with 
previous observations [Figures 12 and 13] where it was demonstrated that the 
enzyme immunoprecipitates efficiently with the ctMGS, but the detection by 
Western blot was better with the pS640MGS antibody in Sertoli cell extracts. 
Hence, with the immunoprecipitation of the enzyme complete, the first 
part of the assay was successful and allows continuing with the RIP analysis.  
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Figure 18. MGS co-immunoprecipitates with mRNAs. Input and 
immunoprecipitated primary Sertoli cell extracts, from a single experiment 
shown in Figure 18, were heated to revert the crosslinking and treated with 
proteinase K to proceed with the RNA purification. Afterwards, the purified 
RNAs were analysed by mRNA profiling microarray. In A) RNA profiles of 
Input and each immunoprecipitate extract are shown and ploted as 
concentration in fluorescence units [FU] in function of the RNA length in 
nucleotides [nt]. Inside the graphs [top right] the concentrations of each 
extract are shown. The data obtained from the microarray is indicated in B). 
The enrichment of different quantities of mRNAs in the MGS 
immunoprecipitated extracts, ctMGS and pS640MGS, in comparison with the 
negative control are shown in red and green circles for ctMGS and 
pS640MGS, respectively. The number of enriched mRNAs from both MGS 
pull downs are depicted in the intersection of the red and green circles. 
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The other two thirds of each IP were used for RNA purification and the 
samples were assessed to examine the concentration and integrity of the 
immunoprecipitated RNAs. In this quality control, the obtained 
concentrations for the RNAs were 227 ng/uL, 16 ng/uL, 27 ng/uL, and 24 
ng/uL for the Input, Rb IgG IP, ctMGS IP and pS640MGS IP, respectively 
[Figure 18A, numbers inside each graph]. The integrity of the RNAs was 
evaluated by determining the concentration as units of fluorescence, in 
function of the length in nucleotides of the purified RNAs from each extract 
[Figure 18A, graphs]. Besides different concentrations of immunoprecipitated 
RNAs, the graphs showed the presence of two components of the small and 
large subunits ribosomal RNAs, the 18S and 28S, in the ctMGS and 
pS640MGS IPs but not in the control IP [Figure 18, graphs]. Additionally, in 
both MGS RIPs it was observed the presence of RNAs with the average 
length of an mRNA [1000 to 2000 nucleotides], but not in the Rb IgG IP 
[Figure 18, graphs]. This was the main clue to make a valid association 
between the MGS with mRNAs in Sertoli cells. 
Later, the identity of those mRNAs was determined by a microarray, 
from which it was possible to detect the mRNAs in both MGS RIPs in 
comparison with the control [Figure 18B]. It is important to emphasize at this 
point that microarray results were obtained as an enrichment of each mRNA 
in one RIP more than another. In this way, each MGS RIP was compared to 
the negative control. Analysing the mRNAs enriched in the ctMGS RIP 
versus the Rb IgG RIP, 1191 mRNAs were found, while the enriched 
messengers in the pS640MGS RIP versus the Rb IgG RIP were 1474 [Figure 
18B, circles]. Both RIPs share 453 mRNAs with a probability of ≈ 1 to be 
statistically enriched in the MGS RIPs with respect the control [Figure 18B, 
intersection of the circles]. 
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Subsequently, the shared 453 mRNAs were classified and grouped by 
function using the bioinformatic tool PANTHER [Protein ANalysis Through 
Evolutionary Relationships] classification system (Mi et al. 2005, 2013; 
Thomas et al. 2003). The result of this analysis helped to organize the 
microarray data according to the molecular function and biological processes 
[Figure 19, graphs]. From a total of 453 mRNAs encoded genes, 45 of them 
were not identified, while 408 of them could be associated with different 
categories. The classification of them by molecular function showed that 163 
[40% of the total] genes were related to binding [grey bar upper graph, Figure 
19A]. From this 163, almost all are linked to nucleic acid binding and protein 
binding [yellow and light blue bars respectively, lower graph, Figure 19A]. In 
the same way, by classifying the genes by their biological function it was 
observed that 188 [46.1% of the total] genes were associated with a category 
of metabolic processes [red bar, upper graph, Figure 19B] and also almost all 
of them, in relationship with primary metabolic processes [orange bar, lower 
graph, Figure 19B]. It is important to clarify that this latter category was 
essentially related to protein and nucleobase, nucleoside, nucleotide and 
nucleic acid metabolic processes where transcription was highly predominant. 
In brief, these results suggested that MGS is effectively interacting with 
RNAs, whether rRNA or mRNA. 
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Figure 19. The MGS interacting mRNAs are mainly associated to 
primary metabolic processes in Sertoli cells. Bioinformatic classification 
of the 453 mRNAs that co-immunoprecipitate with the MGS showed in 
Figure 18. The mRNAs were classified by it molecular function A) and 
biological process B) using the bioinformatic tool for gene classification 
PANTHER. For both cases, the terms are associated with colours and bar 
graphed. The categories with more components indicate the percentage of 
enrichment over the correspondingly bar. Upper graphs show the enriched 
category from the total number of analysed mRNAs. Bottom graphs indicate 
the distribution of each enriched term in the upper graphs. 
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5. Discussion 
 
5.1 MGS characterization in Sertoli cells 
In this work the functional characterization of muscle glycogen 
synthase and its possible unknown non-metabolic role in Sertoli cells was 
studied. By comparing both Sertoli cell types with testicular extracts, some 
characteristics of the enzyme were identified. MGS mRNA was marginally 
detectable by RT-PCR in testicular extracts but was clearly expressed in both 
Sertoli cell types, despite the same amount of RNA load [Figure 3A]. 
Likewise, this was observed at the protein level where Western blot analyses 
showed that MGS was almost undetectable in testes in contrast to the levels 
present in Sertoli cells, and despite the higher protein loading of testicular 
extracts [Figure 3B]. These results indicate that Sertoli cells are enriched in 
MGS when compared to other testicular components. Therefore, the reduced 
amount of the enzyme observed in testicular extracts can be explained by 
mass dilution. These results agree with what was described in the late 1960s, 
indicating that testicular glycogen is abundant in prepubertal testes (sexually 
immature) enriched in Sertoli cells with a few spermatogonia (Fabbrini et al. 
1969, Fouquet & Guha 1969). Also, this coincides with a recent publication of 
our laboratory that showed that Sertoli cells and not germ cells were the main 
source of testicular glycogen (Villarroel-Espíndola et al. 2013). 
The cellular localization of the endogenous enzyme in Sertoli cells was 
different when compared with the most frequent cellular model of MGS 
studies, muscle cells. Until now there have been no reports about nuclear 
localization of the endogenous enzyme; only two of them have demonstrated 
the nuclear localization of overexpressed MGS in glycogen deprived muscle 
cells by culturing them in the absence of glucose (Cid et al. 2005, Ferrer et al. 
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1997). Cellular fractionation and co-immunofluorescence assays [Figures 4A 
and 4B] revealed for the first time, without disturbing any cellular processes 
by protein overexpression, that endogenous MGS was located in the nucleus. 
Specifically, the pS640MGS form was located in sub-nuclear structures named 
speckles, where the pre-mRNA splicing machinery occurs and the 
phosphorylated enzyme colocalizes with the splicing factor SC-35 [Figure 4B]. 
The nuclear localization of the endogenous enzyme in Sertoli cells, 
without depriving them of glycogen and maintaining the cultures in the 
presence of glucose, led us to analyse the activation state of MGS. To 
accomplish this analysis, glycogen synthase activity was measured in primary 
and 42GPA9 Sertoli cells, indicating for both cases that the enzyme was 
present but almost in an inactive state [Figure 5]. The activity ratio [–G6P 
activity/+G6P activity] revealed that the proportion of active enzyme in both 
cell types was very similar, confirming the cell line 42GPA9 as a good model 
for MGS studies in Sertoli cells. 
The extremely low activity rates of MGS observed in Sertoli cells led us 
to consider that the enzyme could be present in a high phosphorylated state, 
and possibly in the Ser640 because it is the main phosphorylation site that 
inactivates the enzyme (Palm et al. 2013, Skurat et al. 1994). Phospho-Ser 
640MGS and total MGS levels were evaluated by phosphatase assays, which 
suggest that this enzyme could be present in a high-phosphorylated state 
[Figure 6]. An important point to discuss is how the antibodies can detect the 
enzyme from Sertoli cell extracts. For both Sertoli cell types, pS640MGS was 
easily detectable in the absence of phosphatase, but this signal decreased in 
the presence of the phosphatase indicating the success of the assay. 
Meanwhile, when total MGS was detected [with the ct-MGS and 3886 MGS 
antibodies], it was clearly more detectable after the treatment with λ 
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phosphatase. Thus, these assays helped us to reveal that dephosphorylation 
could facilitate the exposure of epitopes for total MGS antibodies, which 
function better when the enzyme is dephosphorylated, and more importantly, 
is consistent with MGS being present in a highly phosphorylated state in 
Sertoli cells. 
Moreover, the possibility that MGS could be inactive due to high levels 
of phosphorylation could be sustained by two dimensional gel electrophoresis 
where some spots to acidic pH [pH 5.55-5.8] were observed for the 
immunoprecipitated Sertoli MGS [Figure 7, bottom gel]. The more acidic 
forms of the enzyme suggest that MGS could be phosphorylated in different 
residues, where muscle and brain MGS are not, because the main covalent 
post-translational modifications of the enzyme are phosphorylations. MGS 
has 15 putative sites of phosphorylation where only nine have been 
established in vivo (Poulter et al. 1988) indicating that MGS phosphorylation 
pattern could differ depending on a cell type, tissue, metabolic state or stimuli. 
Accordingly, evident differences were observed for Sertoli MGS two 
dimensional gel electrophoresis pattern, in comparison with the muscle and 
brain enzyme. The Sertoli MGS pattern showed a set of eight spots to more 
acidic pH [pH 5,5-6,3], and one spot localized to a more basic pH [pH 7]. The 
more acidic Sertoli MGS spots [pH 5.55-5.8] were not observed in muscle 
MGS, but only there is some grade of similarity to the brain MGS. Thus, in 
summary, these results indicate that endogenous Sertoli MGS is located in the 
nucleus and cytoplasm, and is present as an almost inactive enzyme possibly 
due to high levels of phosphorylation. 
To demonstrate if the inactive MGS could be susceptible to activation, 
two already described methods were performed. One, based on Protein 
Targeting to Glycogen [PTG] overexpression that induces the 
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dephosphorylation of MGS, and another, established in different publications 
as an indirect activator of the MGS through the inhibition of GSK3 with 
lithium salts (Greenberg et al. 2003, MacAulay et al. 2003, Oreña et al. 2000, 
Vilchez et al. 2007). PTG overexpression by adenovirus infection of Sertoli 
42GPA9 cells produced an increase in the intrinsic glycogen synthase activity 
[-G6P], without changing the total activity [+G6P], meaning that PTG 
overexpression was effectively activating the enzyme without changing its 
expression levels. The increment in the activity was evidenced by the activity 
ratio –G6P/+G6P, reaching values near 0.32 from the 0.024 observed in non-
infected Sertoli cells. This ratio indicates the portion of the expressed enzyme 
that is active, where values below 0.1 correspond to totally inactive enzyme 
and those over 0.7 denote a totally active enzyme. Sertoli MGS activation was 
not total, because the activity ratio –G6P/+G6P reached only 0.32 [Figure 
8C]. This could be explained by an inefficient infection or using a small 
number of adenoviral particles. For both Sertoli cell types the same amount of 
adenoviral particles were used. Nevertheless, the infection efficiency can differ 
between both Sertoli cell types. 
Additionally, the incomplete activation can be due to some mechanism 
that prevents the over activation of the enzyme by PTG in Sertoli cells. This 
idea is supported by the observed high levels of pS640MGS and could be 
sustained by the presence of Malin and Laforin in Sertoli cells (Villarroel-
Espíndola et al. 2013), which promotes PTG poli-ubiquitination and 
proteasome degradation (Worby et al. 2008). Another explanation for the mild 
activation of MGS by PTG overexpression can be explained by a deficiency in 
the levels of the allosteric activator [G6P]. During total activity assays, G6P is 
added to a final concentration of 6.6 mM, while during intrinsic activity 
measurement the concentration of G6P depends on how much of this 
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metabolite is present in the cell lysate. Thus, having in mind that Sertoli cells 
convert more than 95% of the incorporated glucose into lactate via glycolysis, 
the G6P concentration in these cells could be very low because the 
equilibrium of the glucose metabolism is shifted to lactate production via 
glycolysis. For this reason, higher levels of activation were obtained only in 
total activity assays and not during AdPTG overexpression or intrinsic activity 
measurements. Despite the mild activation in PTG infected cells, the glycogen 
content increased more than 30 and 100 times compared to the controls for 
primary Sertoli and 42GPA9 Sertoli cells, respectively [Figure 8D]. 
By contrast, the previously described activator of the MGS, lithium 
chloride, generated a very weak increase in the intrinsic activity and a decrease 
of the total activity, resulting in a faint rise in the activity ratio –G6P/+G6P 
with respect to the control [Figure 9A and B]. Likewise, lithium induced the 
formation of pS640MGS granules and an electrodense glycogen-like structure 
in the cytoplasm of 42GPA9 Sertoli cells [Figure 10A and B]. It is important 
to note that the nuclear localization of the phosphorylated enzyme did not 
change during lithium treatments. In primary Sertoli cells obtained from mice 
treated with therapeutic doses of lithium, the same cytosolic granule of 
pS640MGS was observed [Figure 10C]. Hence, lithium effects on Sertoli cells 
must be examined carefully, because MGS in these cells does not respond as 
has been described in other models where the enzyme is activated and 
relocated to a large number of glycogen particles (Oreña et al. 2000, Vilchez et 
al. 2007). The small increase in the activity ratio –G6P/+G6P during lithium 
treatments can be explained by a decrease in the total activity in addition with 
a lesser increase in the intrinsic activity with respect to non-treated cells. 
Despite this, glycogen content increased 2 and 3 times in primary Sertoli and 
42GPA9 Sertoli cells, respectively. 
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Moreover, the accumulation of the pS640MGS in cytosolic granules in 
addition to the glycogen-like structure observed in lithium-treated 42GPA9 
Sertoli cells could be associated because they are consistent with the glycogen-
dependent subcellular localization (Díaz et al. 2011, Wilson et al. 2010). This 
effect was corroborated in a physiological model of primary Sertoli cells from 
mice treated with therapeutic doses of lithium, supporting the idea that this 
particular accumulation of the enzyme is a glycogen granule as a result of the 
weak activation of the MGS. It is important to highlight that lithium 
treatments cause stress in testicular cells including Sertoli cells (Zarnescu & 
Zamfirescu 2006). In the case of Sertoli 42GPA9 cells, 90 mM lithium 
chloride was added directly to the cell culture medium for 24 hours [acute 
treatment] provoking an osmotic stress. For primary Sertoli cells, the mice 
were treated with therapeutic doses of lithium carbonate for 30 days [chronic 
treatments], which induces the formation of vacuoles. Nevertheless, the 
viability of treated cells did not decrease [data not shown]. 
Thus, by comparing both methods for MGS activation, these results 
indicate that direct dephosphorylation of the enzyme by PP1 through PTG 
overexpression is a more potent approach to induce the glycogen synthesis in 
comparison with the inhibition of GSK3 by lithium on Sertoli cells. 
 
5.2 What is the role of MGS in Sertoli cells? 
 
It was described that MGS in Sertoli cells is present as an almost 
inactive enzyme that cannot be completely activated by two different 
described methods. Then, why do Sertoli cells present an inactive enzyme? Or 
more precisely, what could be the function of the MGS in Sertoli cells? 
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For more than 2 decades, enzymes involved in metabolic processes 
have been linked to RNAs. Glyceraldehyde-3-phospate dehydrogenase 
[GAPDH] was the first glycolytic enzyme to be discovered as a transfer RNA 
[tRNA] binding protein (Ryazanov 1985, Singh & Green 1993). For MGS 
there is only one published study that associates the enzyme with RNA 
metabolism, specifically the pS640MGS was discovered co-sedimenting with 
actively translating ribosomes and its presence regulates the expression of 
different mRNAs in HeLa cells (Fuchs et al. 2011). Therefore, the latter study 
guided us to analyse whether ribonuclear particles could interact with MGS in 
Sertoli cells. 
Argonaute-2 [AGO2] is one of the principal components of the RNA 
processing bodies, and it was highly expressed in Sertoli cells when compared 
with germ cells. In this study MGS was found in close association with AGO2 
and other RNA binding proteins [CPEB1, CPEB4 and DDX6] in Sertoli cells 
by co-immunofluorescence and co-immunoprecipitation assays [Figure 11, 13 
and 14]. Additionally, co-localization of MGS, CPEB1 and Staufen in 
different zones of the cytoplasm of Sertoli 42GPA9 cells was also visualized 
[Supplementary figure 1]. Staufen is a double-stranded RNA binding protein 
acting as an essential factor for mRNA decay in RNA processing bodies and 
stress granules (Barbee et al. 2006, Eulalio et al. 2007, Moser & Fritzler 2010). 
Moreover, during cytosolic MGS granules formation by lithium treatments, 
co-localization of the MGS granules with different components of RNPs like 
AGO2, GW182, and Staufen was also observed [Supplementary figure 2]. 
Hence, these co-immunofluorescence experiments showed that under 
different conditions, some pool of the MGS was always co-localizing with 
different RBPs components in Sertoli cells. 
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Co-immunoprecipitation assays corroborated the efficiency of the 
commercial antibodies to immunoprecipitate MGS from crosslinked Sertoli 
cell extracts [Figure 12]. The crosslinking was made to emulate the first step 
and maintain the same conditions of the RNA immunoprecipitation assay. 
Three MGS antibodies were used to immunoprecipitate the enzyme [ctMGS, 
3886 and pS640MGS] from Sertoli cell extracts, being the ctMGS antibody 
the most successful to pull down the enzyme, which was confirmed by mass 
spectrometry. In addition to MGS, 33 different proteins were found in the 
excised band of ≈80-90 KDa [listed alphabetically in Supplementary figure 
3A]. These proteins were classified by their class and molecular function using 
the bioinformatic tool PANTHER [Protein Analysis Through Evolutionary 
Relationships]. By molecular function, 19 proteins [57.6% of the total] were 
associated to the category of binding. Inside this category, 14 of them link to 
nucleic acid binding, 13 proteins to catalytic activity [38.5% of the total], and 7 
of them relate to helicase activity [Supplementary figure 3B]. By protein class 
classification, 14 proteins [42.2% of the total] were associated to nucleic acid 
binding, and 9 of them specifically to RNA binding [Supplementary figure 
3C]. Thus, a large number of the co-immunoprecipitated proteins with the 
MGS were associated to the category of RNA binding. 
Besides MGS, the second protein enriched in the IP extracts was the 
heat shock protein 90 [HSP90]. This chaperone has been described to be 
required for the interaction between different components of the RNA-
induced silencing complex, like AGO2 and Hiwi with Dicer, through its 
ATPase activity in HEK293T cells (Tahbaz et al. 2004). In the same way, 
HSP90 activity mediates the recruitment of AGO2 to p-bodies and stress 
granules, the assembly of RISC, and the loading of RNA duplexes to AGO2 
in mammals, Drosophila, and plants (Iki et al. 2010, Iwasaki et al. 2010, 
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Makhnevych & Houry 2012, Matsumoto et al. 2011, Meister 2013, Miyoshi et 
al. 2010, Pare et al. 2009). Moreover, with this analysis, it is possible to discard 
a cross-reaction of MGS [≈80-90 KDa] and AGO2 [≈95-105 KDa] 
antibodies, because of the similar molecular weight of them. During pull 
down assays, AGO2 could not be co-immunoprecipitated after the pull down 
of MGS with the ctMGS antibody [Figure 13A]. By contrast, pS640MGS 
could be detected after the immunoprecipitation of AGO2 [Figure 13B]. 
Both results can be explained by the high levels of phosphorylation of 
the enzyme, together with the behaviour of the antibodies against the MGS 
and AGO2 in Sertoli cells. As described in this work, the ct-MGS antibody 
improved the enzyme detection by Western blot when it was 
dephosphorylated [phosphatase assays, Figure 6], or when it was highly 
concentrated [MGS pull down corroboration, Figure 13A], while the 
pS640MGS antibody efficiently detected the phosphorylated enzyme by 
Western blot in Sertoli cells, due to high levels of phosphorylation, even if 
pS640MGS is not concentrated. The latter was observed in the phosphatase 
assays where despite the dephosphorylation treatments, the pS640MGS 
antibody could still detect the portion of the enzyme that remained 
phosphorylated [Figure 6]. 
Accordingly, when MGS was immunoprecipitated with ctMGS 
antibody, AGO2 was not detectable possibly because the AGO2 antibody 
could not detect small amounts of the protein. Nevertheless, when AGO2 
was successfully immunoprecipitated, the pS640MGS antibody was able to 
detect the small quantities of the phosphorylated enzyme in the IP extract. 
This possible explanation is also useful to the co-IPs of the pS640MGS with 
the different RBPs, where different levels of the phosphorylated enzyme in 
each pull down extract was observed in both Sertoli cell types [Figure 14]. 
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Different RBPs interact with other proteins depending on the presence 
of an RNA molecule like the RNAse DICER and the HIV transcription 
activator Tat (Bennasser & Jeang 2006). In other cases, the interaction of a 
known RBP, like the human antigen R [HuR], with myosin IIA is strictly 
RNA dependent and requires their phosphorylation (Doller et al. 2013). 
Nevertheless, in this work the interaction of pS640MGS and AGO2 was not 
dependent on an RNA molecule neither on the MGS activity state [Figure 15]. 
It seems that the pS640MGS/AGO2 interaction was determined by the 
phosphorylation of the enzyme, because despite the PTG overexpression, the 
remaining phosphorylated enzyme was still interacting with AGO2 [Figure 
15]. Therefore, it would be interesting to investigate which of the 
phosphorylation sites/domains of the MGS are essential for this interaction. 
These could be achieved by the mutation of the phosphorylatable serines [Ser 
to Ala mutations], by mimicking the phospho-serines [Ser to Asp mutations], 
or deleting specific regions to prove whether this interaction still occurs. 
Considering the interaction of pS640MGS with AGO2 and other 
RBPs, and that all these RBPs are associated with mRNAs, the interaction of 
the phosphorylated enzyme with mRNAs was examined. To prove this 
interaction, RNA inmunoprecipitation assay [RIP] followed by an RNA 
profiling of the co-immunoprecipitated mRNAs was evaluated. The RIP was 
performed using the ctMGS and pS640MGS antibodies for the MGS, and an 
anti rabbit IgG as a negative control for the assay. Both MGS antibodies were 
used to make a duplicate of the RIP, because the ctMGS antibody should 
detect the phosphorylated enzyme during the IP, and all the information of 
the mRNA microarray of the pS640MGS RIP should be found in the ctMGS 
RIP. Before the mRNA profiling, the success of the MGS IP with both 
antibodies was corroborated, and as previously mentioned, the ctMGS 
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antibody was very efficient to immunoprecipitate the enzyme but not to 
detect it in the blots [Figure 17, up]. In contrast, the pS640MGS was 
ineffective to pull down the enzyme in comparison with ctMGS, but not to 
detect the phosphorylated enzyme in the blots as was visualized in the input 
and unbound lanes [Figure 17, down]. 
Therefore, after MGS pull down, RNA purification was performed 
with good yields and RNA integrity in each IP extract. Despite the differences 
in the MGS pull down observed by Western blot, comparable concentrations 
of RNA were obtained [27 ng/uL for ctMGS and 24 ng/uL pS640MGS]. 
Additionally, similar patterns of fluorescence where mean mRNAs in length 
should be visualized and the presence of the 18S and 28S ribosomal subunits 
were found in both MGS IPs [Figure 18A]. In the Rb IgG IP less RNA 
concentration [16 ng/uL] was obtained and practically all concentrated RNAs 
were of less than 200 nt in length, without detecting the ribosomal subunits. 
Hence, the detection of small and large ribosomal subunits 
immunoprecipitating with the MGS are in strong concordance with the 
observed association of the phosphorylated enzyme with ribosomal subunits 
in Hela cells (Fuchs et al. 2011). 
As pS640MGS IP was notably lower in comparison with ctMGS IP, 
and taking into account the obtained data of the RNA quality control, it is 
possible to suggest that there are different populations of the enzyme in 
Sertoli cells. One portion of the enzyme would be bound to the few observed 
glycogen amounts, able to be dephosphorylated by PP1-PTG, and able to 
achieve glycogen synthesis during certain periods or stimulus. This could 
correspond to a portion of total MGS that is unphosphorylated, in addition to 
the enzyme that is phosphorylated and accessible to be dephosphorylated. 
Meanwhile the other portion of the enzyme could have an unknown role by 
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its interaction with RBPs and RNAs, which would correspond uniquely to the 
phosphorylated enzyme that is not accessible to be dephosphorylated, because 
is not bound to glycogen. 
The number of mRNAs in each RIP also supports this idea. For the 
ctMGS RIP a total of 1191 mRNAs were obtained, while for the pS640MGS 
RIP 1474 mRNAs that had higher fold changes with respect to the negative 
control, 453 were shared [Figure 18B, ctMGS-Rb IgG and pS640MGS-Rb 
IgG]. Interestingly, despite the strong immunoprecipitation of the enzyme 
with the ctMGS in comparison to the pS640MGS, more mRNAs were found 
after the MGS pull down with the pS640MGS. This suggests that the 
observed mRNAs in the ct-MGS IP correspond to the mRNAs found in the 
pS640MGS IP, corroborating the idea that the phosphorylated enzyme is 
interacting with RNAs. 
Mouse cells can transcribe more than 30,000 genes giving at least the 
same number of mRNAs. For this reason, the shared 453 mRNAs between 
both MGS RIPs would correspond to a specific population of mRNAs. To 
find some predominant function associated with these mRNAs, a 
classification of different categories according to their molecular function or 
biological process was performed [Figure 19A and B]. Regarding the 
molecular function, two main categories were obtained, binding [nucleic acid 
and protein binding] and catalytic activity [Figure 19A]. For the binding 
category, DNA binding was enriched in comparison with the RNA and 
protein binding, and was mainly related to transcription factor activity with 48 
genes that correspond to 10.5% of the total 453 mRNAs encoded genes. 
Whereas for the catalytic activity category, no predominant term was 
observed. Then, the classification by biological process revealed a principal 
category, metabolic process, with nearly the half of the genes [Figure 19B, up]. 
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Remarkably, this category was almost exclusively constituted by genes related 
to primary metabolic processes [Figure 19B, down], which in turn, were 
fundamentally composed by two categories: nucleobase, nucleoside, 
nucleotide and nucleic acid metabolic process where transcription was the 
category with the higher number of genes, as was expected by the molecular 
function classification. The other main category was protein metabolic 
process where no enriched term was found. After the identification and 
classification of the mRNAs of both RIPs, it is possible to suggest that 
pS640MGS is interacting with a population of mRNAs mostly associated with 
the process of transcription in Sertoli cells.  
In this point is important to highlight the fact that MGS was not 
immunoprecipitated alone during the RIP assays, and that many of the 
proteins found pulled down with the enzyme are RNA binding proteins. This 
means that many of the enriched mRNAs found in the IP´s were not uniquely 
pulled down by the MGS. 
To identify the possible role of MGS in Sertoli cells, the association of 
MGS to RNAs and RBPs was explored. As described earlier, many metabolic 
enzymes have been related to RNA metabolism and even regulating their own 
mRNAs. One important feature of some metabolic enzymes that interact with 
RNAs is the presence of two identical ß-α-ß folds, each one is associated with 
a nucleotide binding surface called Rossmann fold (Buehner et al. 1973, Singh 
& Green 1993). This structural domain has been described to bind 
nucleotides, and specifically nicotinamide adenine dinucleotide [NAD+] in 
different glycolytic enzymes. Among them, it is possible to find some 
dehydrogenases, like lactate dehydrogenase [LDH] and glyceraldehyde-3-
phosphate dehydrogenase [GAPDH], and kinases, like phosphoglycerate 
kinase [PGK] (Nagy et al. 2000, Pioli et al. 2002, Shetty et al. 2004). In the 
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case of LDH and GAPDH, which have been studied in more detail, NAD+ 
inhibits the RNA binding capacity of these proteins by competing with RNAs 
for the Rossmann fold, making the protein/RNA interaction dependent on 
NAD+ concentration (Nagy & Rigby 1995, Nagy et al. 2000, Pioli et al. 2002). 
Moreover, it is important to highlight that enzymes that bind to mRNA AU-
rich elements in the 3`UTR were found associated with polysomes and 
interacting with cytoskeleton structures (Arnold et al. 1971, Nagy & Rigby 
1995, Pioli et al. 2002, Walsh et al. 1989). 
MGS localization has been reported to be directed by the remodeling 
actin filaments in rabbit muscle cells (Prats et al. 2005). Additionally, this 
enzyme belongs to the family of glycosyltransferases [GT] and specifically to 
the GT3, because of the use of UDP-glucose as a substrate and its tight 
regulation by reversible phosphorylation and allosteric effector [G6P]. 
Glycosyltransfereases contain conserved domains that topologically resembles 
the Rossmann fold, with two Rossmann domains separated by a large cleft 
where the catalysis occurs (Buschiazzo et al. 2004, Horcajada et al. 2006, 
Vrielink et al. 1994). Thus, MGS shares different features with other 
metabolic enzymes that bind RNA like the association with polysomes, 
cytoskeleton interaction and the Rossmann fold like topology.  
Archaeal glycogen synthase crystallization and human MGS mutational 
studies have determined that this enzyme has a high affinity glycogen binding 
site, which is different to the acceptor site in the catalytic cleft and determines 
the interaction between the enzyme and the polysaccharide (Díaz et al. 2011). 
This indicates that MGS is anchored to glycogen molecules by the high 
affinity site, and synthetizing glycogen through the low affinity glycogen-
binding site in the catalytic cleft. 
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Glycogen content in Sertoli cells is very low [≈ 4 ug/mg protein] in 
comparison with astrocytes [≈40 ug/mg protein] or when the enzyme was 
partially activated by PTG overexpression [≈740 ug/mg protein]. 
Additionally, the protein level of MGS is abundant and does not correlate 
with the low levels of glycogen, leaving the question about where MGS is 
anchored in Sertoli cells. A possible answer to this question fits well with the 
previous idea that suggests the presence of different populations of MGS in 
Sertoli cells. One fraction of the enzyme that is susceptible to be activated for 
glycogen synthesis should be bound to the small number of glycogen particles 
through both glycogen-binding sites. The non-catalytic/glycogen high affinity-
binding site should be used to position the enzyme for catalysis, while the 
catalytic/glycogen low affinity-binding site would interact with other glycogen 
molecules as a primer for the polysaccharide polymerization. On the other 
hand, another population of the MGS that is not anchored to glycogen 
particles and cannot be activated must be interacting with other molecules 
through any of both glycogen-binding sites. 
This proposal can be sustained by the two dimensional gel 
electrophoresis assays, where two different populations of the enzyme were 
clearly observed. The spot that have a more basic isoelectric point [pH 7] 
might compose one fraction. The fraction that could correspond to the 
enzyme that is less [or not] phosphorylated, bound to few molecules of 
glycogen, susceptible to be dephosphorylated and that achieves glycogen 
synthesis in Sertoli cells. While the fraction of MGS that has an acidic 
isoelectric point, could correspond to the enzyme that is more 
phosphorylated, bound to RNAs and RBPs, cannot be dephosphorylated and 
is achieving a non-metabolic function in Sertoli cells. In this case it can be 
suggested that MGS could interact with mRNAs or rRNAs through the 
! 114!
catalytic/glycogen low affinity-binding domain. The catalytic/glycogen low 
affinity-binding site utilizes UDP-glucose for catalysis, and perhaps the UDP 
extreme of the nucleotide sugar can be recognized by the catalytic cleft of the 
enzyme. This idea is also supported by the fact that LDH and GAPDH bind 
to AU-rich elements in the 3`UTR of the mRNAs (Nagy & Rigby 1995, Pioli 
et al. 2002). Thus, if the catalytic/glycogen low affinity-binding site could 
interact with RNA molecules, the non-catalytic/glycogen high affinity-binding 
site must be kept free, but able to bind glycogen without being activated. This 
effect could be observed during lithium treatments, where the scarce 
activation of glycogen synthesis only duplicates the glycogen content. In this 
way, if small amounts of glycogen are available in the cytoplasm, the free non-
catalytic/glycogen high affinity-binding site should interact with it, and the 
consequence could be the formation of cytosolic granules of the 
phosphorylated MGS that were still co-localizing with RBPs during lithium 
treatments. 
Sertoli cells achieve a structural function supporting germ cell 
development through the seminiferous epithelium and as a nutritional supply 
of lactate for developing germ cells. Sertoli cell metabolism is essential for 
maintaining the spermatogenic process, and thus, male fertility. Carbohydrate 
metabolism in Sertoli cells is focused in lactate production through glycolysis, 
since a high percentage of the incorporated glucose is converted to lactate 
while less than a 5% is converted to CO2, lipids and glycogen (Robinson & 
Fritz 1981). Interestingly, glycogen synthesis was not induced in the presence 
of insulin (Robinson & Fritz 1981). Even in the absence of glucose, Sertoli 
cells change their metabolism to maintain the lactate production by the 
activation of AMP-activated kinase [AMPK] and stimulating catabolic 
pathways (Riera et al. 2009). Moreover, lipids have been described as the main 
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source of energy for Sertoli cells via lipid β oxidation, because ATP 
production decreases only when lipid β oxidation, and not glycolysis, was 
blocked (Xiong et al. 2009). 
In this biological scenario, the presence and the contribution of 
glycogen to Sertoli cell carbohydrate metabolism is scarce and the results of 
this study support it. Sertoli cells produce low amounts of glycogen and this 
agrees with the almost total inactivity of glycogen synthase. A relevant issue is 
that Sertoli cells used in this work were obtained from sexually mature mice, 
where Sertoli cells are totally differentiated and their metabolism works as was 
described above. 
Mature Sertoli cells do not proliferate and are fundamental to 
maintaining spermatogenesis by hormonal control (Alves et al. 2013), while 
during embryonic stages, pre-Sertoli cells are involved in testes formation 
through the activation of the master gene Sry. Glycogen accumulation and 
SOX9 expression occurs immediately after the transient activation of Sry in 
pre-Sertoli cells, indicating that testicular cord formation during 
testiculogenesis needs an energetic support like glycogen (Kanai et al. 2005, 
Matoba et al. 2005, 2008). Furthermore, in mice lacking the insulin receptor 
family that usually activates glycogen synthesis, Sry activation and SOX9 
expression were reduced, indicating that the insulin signalling pathway is 
essential for pre-Sertoli cells during male sex determination (Nef et al. 2003). 
This suggests that during testicular organogenesis, glycogen synthase must be 
activated to synthesize glycogen and maintain the expression of SOX9 after 
the activation of Sry in immature Sertoli cells. For these reasons, it is possible 
to propose that in immature Sertoli cells, during male sex determination in 
embryonic stages, glycogen synthase achieves a metabolic role induced by 
insulin signalling, while in mature Sertoli cells, MGS is not focused on 
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performing this metabolic role due to the observed small amounts of glycogen 
and could be accomplishing other functions related to RNA metabolism.  
Neurons are other cell models where the glycogen synthesis machinery 
is present, but in an inactive form (Vilchez et al. 2007). However when the 
malin-laforin complex is truncated, by mutations in any of their components, 
the proteasome dependent degradation of PTG is inhibited promoting the 
glycogen accumulation because of the enforced expression of PTG in neurons 
(Vilchez et al. 2007). In this work the overexpression of PTG stimulates the 
dephosphorylation of MGS, and as was presented in this work, the activation 
of the glycogen synthesis. This suggests that MGS in neurons is maintained 
inactive and possibly accomplishing the same non-metabolic function 
similarly to Sertoli cells. In the same way, is important to emphasize the 
phosphorylation level of MGS, because in this work the observed neuronal 
apoptosis was due to the dephosphorylation of the enzyme. 
In the work of Fuchs et. al. 2011 the enzyme was silenced with siRNAs 
and the translation of a subset of transcripts related with protein biosynthesis 
were affected in addition with a loss of polysomes. Interestingly, in GSK3β 
depleted cells the loss of polysomes was very similar to the observed during 
MGS depletion, suggesting the relevance of the MGS phosphorylation by 
GSK3β could be important for this possible new role of the translational 
regulation of mRNAs expression. Thus, the aforementioned data presented in 
this study suggest that MGS role in mature Sertoli cells could be associated 
with the post-transcriptional gene regulation of mRNAs related to 
transcription. 
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6. Supplementary Figures 
 
 
 
 
 
 
 
 
 
Supplementary figure 1. MGS co-localize with CPEB1 and Staufen in 
Sertoli cells. Co-immunofluorescence study of fixed and permeabilized 
Sertoli 42GPA9 cells. The cells were incubated with antibodies against total 
MGS [green], CPEB1 [red] and Staufen [blue] in a dilution of 1:200, and then 
with the secondary antibodies Alexa-488 donkey anti mouse IgG, Alexa-568 
donkey anti goat IgG and Alexa-633 donkey anti rabbit IgG in a dilution of 
1:300. Co-localization of the immunofluorescent signals are shown in 
MERGE. Scale bars, 20 um. 
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Supplementary figure 2. MGS granules co-localize with GW182, AGO2 
and Staufen in lithium treated Sertoli cells. Co-immunofluorescence study 
of fixed and permeabilized Sertoli 42GPA9 cells previously treated with 
30mM LiCl for 24 hours. As is shown for each case, the cells were incubated 
with antibodies against GW182, AGO2, Staufen, total MGS [MGS] and its 
phosphorylated form in serine 640 [pS640MGS] in a dilution of 1:200. Then 
the secondary antibodies Alexa-568 donkey anti mouse IgG, Alexa-568 
donkey anti goat IgG and Alexa-488 donkey anti rabbit IgG were added in a 
dilution of 1:300. Co-localization of the fluorescent signals and it zoom are 
indicated in white squares for each image. Scale bars, 10 um. 
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Supplementary Figure 3. MGS interacting proteins are mainly 
associated to RNA binding in Sertoli cells. MGS was immunoprecipitated 
using 3 different antibodies and these extracts were loaded and run in 8% 
SDS-PAGE. The band that corresponds to MGS by size was excised and 
analysed by mass spectrometry. In A) are listed the proteins that were found 
additionally to the MGS in the excised band. These proteins were classified by 
its molecular function B) and protein class C) using the bioinformatic tool for 
gene classification PANTHER. For both cases, the terms are associated with 
colours. The categories with more components are highlighted in yellow and 
the correspondingly piece of the pie graph is detached. Black arrows indicate 
the distribution of each enriched term with another pie graph. 
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